Plant disease control composition and method for controlling plant disease by applying the same

ABSTRACT

Provided is a plant disease control composition having a broad spectrum against various plant pathogens, and shows excellent controlling effects (synergistic controlling effects) which cannot be expected from a single component alone. The plant disease control composition comprises (Group a) at least one quinoline compound represented by the formula: 
     
       
         
         
             
             
         
       
     
     (wherein R 1 , R 2 : an alkyl which may be substituted, an aryl which may be substituted, etc.; R 3 , R 4 : H, an alkyl which may be substituted, etc.; X: halogen, an alkyl which may be substituted, etc.; Y: halogen, alkyl, etc.; n: 0 to 4; m: 0 to 6) or a salt thereof, and at least one of fungicidal compounds selected from the group consisting of a Strobilurin series compound, a triazole series compound, etc., as effective ingredients.

TECHNICAL FIELD

The present invention relates to a plant disease control compositionwhich comprises (Group a) at least one quinoline compound represented bythe formula (I) or a salt thereof and (Group b) at least one fungicidalcompound selected from the group consisting of Group 1 (b-1) to 28(b-28) as effective ingredients and a method for controlling plantdiseases by applying the composition.

BACKGROUND ART

A number of chemical agents have heretofore been used for controllingplant diseases. However, the problem that plant pathogens have acquiredresistance to the chemical agents becomes remarkable due to frequent useor excessive application, etc., of the chemical agents having similarstructures and same functions for controlling the same kinds ofdiseases.

On the other hand, consumers' needs for agricultural chemical-reducedcrops and social needs to reduce environmental loads due to agriculturalchemicals have now increased.

Also, in a farmer's field where the chemicals have been actually used,when two or more kinds of chemicals are used in admixture for thetreatment by the tank mix method, there are many risks to lower theeffect of the other chemical to be mixed with each other orpossibilities to cause chemical damages against plant materialsdepending on a combination of chemicals where they are not well-suitedto each other.

Under such a situation, it has been desired to develop a plant diseasecontrol composition having high effects against fungi or bacteria whichare resistant to existing chemicals, and having high effects with a lowamount of an effective ingredient. Moreover, for the purpose ofpreventing plant pathogens from obtaining resistance, it has also beendesired to develop a plant disease control composition comprisingcomponents (compounds) having different basic structures and differentfunctions with well-suited to each other, and a method for controllingplant diseases.

It has been known that a quinoline compound represented by the formula(I) shows, as a fungicide, controlling effects to rice blast(Pyricularia oryzae) and gray mold (Botrytis cinerea) of tomato,cucumber and kidney bean, etc., by an application method such as seeddisinfection, foliar spray treatment, etc. (Patent Literatures 1 to 4).

However, it has never been known yet about a controlling effect of thequinoline compound represented by the formula (I) and the otherfungicide(s) in admixture.

[Patent Literature 1] WO 2005/070917A [Patent Literature 2] JP2007-1944A [Patent Literature 3] WO 2007/011022A [Patent Literature 4]JP 2007-217353A DISCLOSURE OF THE INVENTION Problems to be Solved by theInvention

The present inventors have investigated a combination of the quinolinecompound represented by the formula (I) and the other fungicidalcomponent(s), and as a result, they have found that by combining thequinoline compound represented by the formula (I) and a specificfungicidal compound(s), excellent controlling effects (synergisticeffects) against various plant pathogens can be obtained, which couldnever be expected from the single component alone, stable prophylaxiseffect can be obtained against the existing fungi and bacteria resistantto chemicals, and no chemical damage to plants occurred to accomplishthe present invention.

An object of the present invention is to provide a novel plant diseasecontrol composition having a broad spectrum against various kinds ofplant pathogens, having high plant disease controlling effects againstexisting fungi and bacteria resistant to chemicals, showing highactivity even when amounts of effective ingredients to be applied toenvironment where fungi or bacteria are living are low, and showing nochemical damage against plants, and a method for controlling plantdisease by applying the composition.

Means to Solve the Problems

The present invention comprises a plant disease control compositioncontaining (Group a)

(a) at least one kind of a quinoline compound represented by the generalformula (I):

[wherein R¹ and R² may be the same or different from each other, andeach represents

a C₁ to C₆ alkyl group which may be substituted by the same or different1 to 3 substituent(s) selected from the group consisting of a halogenatom, a C₁ to C₆ alkoxyl group, a C₁ to C₆ alkylthio group and a phenoxygroup;

an aryl group which may be substituted by the same or different 1 to 6substituent(s) selected from the group consisting of a halogen atom, aC₁ to C₆ alkyl group which may be substituted by the same or different 1to 3 halogen atom(s), a C₁ to C₆ alkoxyl group, an amino group which maybe substituted by the same or different 1 or 2 C₁ to C₆ alkyl group(s)or acyl group(s), a nitro group, a cyano group, a hydroxyl group, amercapto group and a C₁ to C₆ alkylthio group;

a heteroaryl group which may be substituted by the same or different 1to 6 substituent(s) selected from the group consisting of a halogenatom, a C₁ to C₆ alkyl group which may be substituted by the same ordifferent 1 to 3 halogen atom(s) and a C₁ to C₆ alkoxyl group; or

an aralkyl group which may be substituted by the same or different 1 to6 substituent(s) selected from the group consisting of a halogen atom, aC₁ to C₆ alkyl group which may be substituted by the same or different 1to 3 halogen atom(s), a C₁ to C₆ alkoxyl group, an amino group which maybe substituted by the same or different 1 or 2 C₁ to C₆ alkyl group(s)or acyl group(s), a nitro group, a cyano group, a hydroxyl group, amercapto group and a C₁ to C₆ alkylthio group, or,

R¹ and R² form, in combination with the carbon atoms to which they arebonded, a C₃ to C₁₀ cycloalkyl ring which may be substituted by the sameor different 1 to 3 substituent(s) selected from the group consisting ofa halogen atom, a C₁ to C₆ alkyl group, a C₁ to C₆ alkoxyl group and aphenoxy group,

R³ and R⁴ may be the same or different from each other, and eachrepresents

a hydrogen atom;

a C₁ to C₆ alkyl group which may be substituted by the same or different1 to 3 substituent(s) selected from the group consisting of a halogenatom, a C₁ to C₆ alkoxyl group, a C₁ to C₆ alkylthio group and a phenoxygroup;

a halogen atom;

a C₁ to C₆ alkoxyl group; or

a hydroxyl group, or,

R³ and R⁴ form a C₁ to C₆ alkylidene group or an oxo group incombination thereof; or

form, in combination with the carbon atoms to which they are bonded, aC₃ to C₁₀ cycloalkyl ring which may be substituted by the same ordifferent 1 to 3 substituent(s) selected from the group consisting of ahalogen atom, a C₁ to C₆ alkyl group, a C₁ to C₆ alkoxyl group and aphenoxy group;

X may be the same or different from each other when n is 2 to 4, andeach represents

a halogen atom;

a C₁ to C₆ alkyl group which may be substituted by the same or different1 to 3 substituent(s) selected from the group consisting of a halogenatom, a C₁ to C₆ alkoxyl group, a hydroxyl group, a C₂ to C₇alkoxycarbonyl group and a phenoxy group;

a C₂ to C₆ alkenyl group which may be substituted by the same ordifferent 1 to 3 substituent(s) selected from the group consisting of ahalogen atom, a C₁ to C₆ alkoxyl group, a C₂ to C₇ alkoxycarbonyl groupand a phenoxy group;

a C₂ to C₆ alkynyl group which may be substituted by the same ordifferent 1 to 3 substituent(s) selected from the group consisting of ahalogen atom, a C₁ to C₆ alkoxyl group and a phenoxy group;

an aryl group which may be substituted by the same or different 1 to 6substituent(s) selected from the group consisting of a halogen atom, aC₁ to C₆ alkyl group which may be substituted by the same or different 1to 3 halogen atom(s), a C₁ to C₆ alkoxyl group, an amino group which maybe substituted by the same or different 1 or 2 C₁ to C₆ alkyl group(s)or acyl group(s), a nitro group, a cyano group, a hydroxyl group, amercapto group and C₁ to C₆ alkylthio group;

a heteroaryl group which may be substituted by the same or different 1to 6 substituent(s) selected from the group consisting of a halogenatom, a C₁ to C₆ alkyl group which may be substituted by the same ordifferent 1 to 3 halogen atom(s) and a C₁ to C₆ alkoxyl group;

a C₁ to C₆ alkoxyl group;

an amino group which may be substituted by the same or different 1 or 2C₁ to C₆ alkyl group(s) or acyl group(s);

an acyl group;

a cyano group; or,

an N-hydroxy C₁ to C₆ alkaneimidoyl group the hydrogen atom of thehydroxyl group of which may be substituted by a substituent selectedfrom the group consisting of a C₁ to C₆ alkyl group, a C₂ to C₆ alkenylgroup, a C₂ to C₆ alkynyl group, an aralkyl group, an aryl group and aheteroaryl group,

Y may be the same or different from each other when m is 2 to 6, andeach represents

a halogen atom; a C₁ to C₆ alkyl group; a C₁ to C₆ alkoxyl group; or ahydroxyl group,

n represents an integer of 0 to 4, and

m represents an integer of 0 to 6]

or a salt thereof, and

(Group b)

(b) one or more fungicides selected from the group consisting of thefollowing mentioned Groups (1) to (28):

Group (1)

a Strobilurin series compound selected from

-   (b-1-1) Azoxystrobin-   (b-1-2) Kresoxim-methyl-   (b-1-3) Pyraclostrobin-   (b-1-4) Picoxystrobin-   (b-1-5) Fluoxastrobin-   (b-1-6) Dimoxystrobin-   (b-1-7) Orysastrobin-   (b-1-8) Metominostrobin and-   (b-1-9) Trifloxystrobin,

Group (2)

a triazole series compound selected from

-   (b-2-1) Simeconazole-   (b-2-2) Tebuconazole-   (b-2-3) Fenbuconazole-   (b-2-4) Hexaconazole-   (b-2-5) Imibenconazole-   (b-2-6) Triadimefon-   (b-2-7) Tetraconazole-   (b-2-8) Prothioconazole-   (b-2-9) Triticonazole-   (b-2-10) Epoxiconazole-   (b-2-11) Ipconazole-   (b-2-12) Metconazole-   (b-2-13) Propiconazole-   (b-2-14) Cyproconazole-   (b-2-15) Difenoconazole-   (b-2-16) Diniconazole-   (b-2-17) Fluquinconazole-   (b-2-18) Flusilazole-   (b-2-19) Penconazole-   (b-2-20) Bromuconazole-   (b-2-21) Triadimenol-   (b-2-22) Flutriafol-   (b-2-23) Myclobutanil-   (b-2-24) Etaconazole and-   (b-2-25) Bitertanol,

Group (3)

an imidazole series compound selected from

-   (b-3-1) Oxpoconazole fumarate-   (b-3-2) Triflumizole-   (b-3-3) Imazalil-   (b-3-4) Imazalil-S-   (b-3-5) Prochloraz-   (b-3-6) Pefurazoate and-   (b-3-7) Triazoxide,

Group (4)

a carboxamide series compound selected from

-   (b-4-1) Penthiopyrad-   (b-4-2) Flutolanil-   (b-4-3) Furametpyr-   (b-4-4) Boscalid-   (b-4-5) Fenhexamid-   (b-4-6) Cyflufenamid-   (b-4-7) Tecloftalam-   (b-4-8) Mandipropamid-   (b-4-9) Bixafen-   (b-4-10) Carboxin-   (b-4-11) Oxycarboxin-   (b-4-12) Mepronil-   (b-4-13) Silthiofam-   (b-4-14) Thifluzamide-   (b-4-15) Flumetover-   (b-4-16) Ethaboxam-   (b-4-17) Zoxamide-   (b-4-18) Tiadinil-   (b-4-19) Isotianil-   (b-4-20) Diclocymet-   (b-4-21) Fenoxanil-   (b-4-22) Fluopicolide-   (b-4-23) Fluopyram-   (b-4-24) Carpropamid-   (b-4-25) Tolfenpyrad-   (b-4-26)    N-[2-(1,3-dimethylbutyl)phenyl]-5-fluoro-1,3-dimethyl-1H-pyrazol-4-carboxamide-   (b-4-27)    N-{2-[1,1′-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1H-pyrazol-4-carboxamide-   (b-4-28)    3-(Difluoromethyl)-N-(9-isopropyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)-1-methyl-1H-pyrazol-4-carboxamide-   (b-4-29)    3-(Difluoromethyl)-N-[4′-(3,3-dimethylbutyn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazol-4-carboxamide-   (b-4-30)    3-(Difluoromethyl)-N-[4′-(3-methoxy-3-methylbutyn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazol-4-carboxamide    and-   (b-4-31)    3-(Difluoromethyl)-1-methyl-N-[1,2,3,4-tetrahydro-9-(1-methylethyl)-1,4-methanonaphthalen-5-yl]-1H-pyrazol-4-carboxamide,

Group (5)

an acylalanine series compound selected from

-   (b-5-1) Metalaxyl-   (b-5-2) Metalaxyl-M-   (b-5-3) Benalaxyl-   (b-5-4) Benalaxyl-M (Kiralaxyl) and-   (b-5-5) Furalaxyl-M,

Group (6)

a valineamide series compound selected from

-   (b-6-1) Benthiavalicarb-isopropyl and-   (b-6-2) Iprovalicarb;

Group (7)

a sulfoneamide series compound selected from

-   (b-7-1) Cyazofamid-   (b-7-2) Amisulbrom and-   (b-7-3) Flusulfamide

Group (8)

a sulfenamide series compound selected from

-   (b-8-1) Tolylfluanid and-   (b-8-2) Dichlofluanid

Group (9)

a carbamate series compound selected from

-   (b-9-1) Propamocarb-   (b-9-2) Propamocarb hydrochloride-   (b-9-3) Diethofencarb and-   (b-9-4) Pyribencarb

Group (10)

a dithiocarbamate series compound selected from

-   (b-10-1) Mancozeb-   (b-10-2) Maneb-   (b-10-3) Propineb-   (b-10-4) Zineb-   (b-10-5) Metiram-   (b-10-6) Ziram-   (b-10-7) Thiuram and-   (b-10-8) Polycarbamate

Group (11)

a dicarboxylimide series compound selected from

-   (b-11-1) Iprodione-   (b-11-2) Procymidone-   (b-11-3) Captan-   (b-11-4) Vinclozolin-   (b-11-5) Chlozolinate and-   (b-11-6) Folpet

Group (12)

a guanidine series compound selected from

-   (b-12-1) Iminoctadine trialbesilate-   (b-12-2) Iminoctadine-triacetate-   (b-12-3) Guazatine and-   (b-12-4) Dodine

Group (13)

a pyrimidine series compound selected from

-   (b-13-1) Mepanipyrim-   (b-13-2) Fenarimol-   (b-13-3) Ferimzone-   (b-13-4) Cyprodinil-   (b-13-5) Pyrimethanil-   (b-13-6) Nuarimol-   (b-13-7) Dimethirimol-   (b-13-8) Bupirimate and-   (b-13-9) Diflumetorim

Group (14)

a morpholine series compound selected from

-   (b-14-1) Dimethomorph-   (b-14-2) Fenpropimorph-   (b-14-3) Tridemorph-   (b-14-4) Dodemorph and-   (b-14-5) Flumorph

Group (15)

a benzimidazole series compound selected from

-   (b-15-1) Thiophanate-   (b-15-2) Thiophanatemethyl-   (b-15-3) Benomyl-   (b-15-4) Carbendazim-   (b-15-5) Thiabendazole and-   (b-15-6) Fuberidazole

Group (16)

a pyrrole series compound selected from

-   (b-16-1) Fludioxonil-   (b-16-2) Fluoroimide and-   (b-16-3) Fenpiclonil

Group (17)

an organophosphorus series compound selected from

-   (b-17-1) Fosetyl-aluminium-   (b-17-2) Edifenphos (EDDP)-   (b-17-3) Tolclofos-methyl-   (b-17-4) Iprobenfos (IBP) and-   (b-17-5) Pyrazophos

Group (18)

a copper series compound selected from

-   (b-18-1) Cupric hydroxide (Copper hydroxide)-   (b-18-2) Copper-   (b-18-3) Basic copper chloride (Copper oxychloride)-   (b-18-4) Basic copper sulfate (Copper sulfate (tribasic))-   (b-18-5) Oxine-copper-   (b-18-6) Copper sulfate pentahydrate-   (b-18-7) Anhydrous copper sulfate-   (b-18-8) Copper nonylphenolsulfonate (Copper nonylphenylsulfate) and-   (b-18-9) Copper dodecylbenzene sulfate bis(ethylenediamine) complex    salt (DBEDC)

Group (19)

an antibiotics selected from

-   (b-19-1) Kasugamycin hydrochloride hydrate-   (b-19-2) Validamycin-   (b-19-3) Polyoxins A to N-   (b-19-4) Blastcidin-S benzylamino benzene sulfonate-   (b-19-5) Streptomycin-   (b-19-6) Natamycin-   (b-19-7) Mildiomycin and-   (b-19-8) Oxytetracycline

Group (20)

an organic chlorine series compound selected from

-   (b-20-1) Chlorothalonil (TPN)-   (b-20-2) Phthalide and-   (b-20-3) Quintozene

Group (21)

a triazolopyrimidine series compound selected from

-   (b-21-1)    5-Chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo-[1,5-a]pyrimidine-   (b-21-2)    5-Chloro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine-   (b-21-3)    5-Chloro-N-[(1R)-1,2-dimethylpropyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine-   (b-21-4)    5-(Methoxymethyl)-6-octyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine and-   (b-21-5) 5-Ethyl-6-octyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine

Group (22)

a benzoyl compound selected from

-   (b-22-1) Metrafenone and-   (b-22-2)    3-(2,3,4-Trimethoxy-6-methylbenzoyl)-5-chloro-2-methoxy-4-methylpyridine

Group (23)

an ethylenediamine series compound selected from

-   (b-23-1)    Isopropyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)-carbamate-   (b-23-2)    Isopropyl((1S)-2,2-dimethyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)-carbamate-   (b-23-3)    Isopropyl((1S)-1-{[(1-benzofuran-2-ylcarbonyl)amino]methyl}-2-methylpropyl)carbamate-   (b-23-4)    2,2,2-Trifluoroethyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}-propyl)carbamate-   (b-23-5)    2,2,2-Trifluoroethyl((1S)-2,2-dimethyl-1-{[(4-methylbenzoyl)amino]methyl}-propyl)carbamate-   (b-23-6)    2,2,2-Trifluoroethyl((1S)-1-{[(1-benzofuran-2-ylcarbonyl)amino]methyl}-2-methylpropyl)carbamate-   (b-23-7) 2,2,2-Trifluoroethyl    {(1S)-1-methyl-2-[(4-methylbenzoyl)amino]ethyl}-carbamate-   (b-23-8)    Benzyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)carbamate    and-   (b-23-9)    Isopropyl((1R)-2,2,2-trifluoro-1-{[(4-methylbenzoyl)amino]methyl}ethyl)-carbamate

Group (24)

an isoxazolidin series compound selected from

-   (b-24-1) 3-[5-(4-Chloro    phenyl)-2,3-dimethylisoxazolidin-3-yl]pyridine,-   (b-24-2)    3-[2,3-Dimethyl-5-(4-methylphenyl)isoxazolidin-3-yl]pyridine and-   (b-24-3)    3-[2-Isopropyl-3-methyl-5-(4-chlorophenyl)isoxazolidin-3-yl]pyridine

Group (25)

a quinoline series compound selected from

-   (b-25-1) Quinoxyfen-   (b-25-2)    [6-(1,1-Dimethylethyl)-8-fluoro-2,3-dimethylquinoline-4-yl]acetate    and-   (b-25-3)    [6-(1,1-Dimethylethyl)-8-fluoro-2,3-dimethylquinoline-4-yl]methoxyacetate

Group (26)

a thiazolidine series compound selected from

-   (b-26-1)    (2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2-ylidene]acetonitrile    and    (b-26-2)    (2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methylphenyl)-1,3-thiazolidin-2-ylidene]acetonitrile

Group (27)

a pyrazolinone series compound selected from

-   (b-27-1)    1-[(2-Propenylthio)carbonyl]-2-(1-methylethyl)-4-(2-methylphenyl)-5-amino-1H-pyrazol-3-one-   (b-27-2)    1-[(Ethylthio)carbonyl]-2-(1-methylethyl)-4-(2-methylphenyl)-5-amino-1H-pyrazol-3-one    and-   (b-27-3)    1-[(Ethylthio)carbonyl]-2-(1-methylethyl)-4-(2,6-dichlorophenyl)-5-amino-1H-pyrazol-3-one,    and

Group (28)

other fungicides and mildewcides selected from

-   (b-28-1) Hydroxyisoxazol (Hymexazol)-   (b-28-2) Fluazinam-   (b-28-3) Diclomezine-   (b-28-4) Tricyclazole-   (b-28-5) Cymoxanil-   (b-28-6) Famoxadone-   (b-28-7) Fenamidone-   (b-28-8) Chloropicrin-   (b-28-9) Thiadiazine (Milneb)-   (b-28-10) Proquinazid-   (b-28-11) Spiroxamine-   (b-28-12) Fenpropidin-   (b-28-13) Dithianon-   (b-28-14) Pencycuron-   (b-28-15) Isoprothiolane-   (b-28-16) Probenazole-   (b-28-17) Resveratrol-   (b-28-18) Triforine-   (b-28-19) Acibenzolar-S-methyl-   (b-28-20) Pyroquilon-   (b-28-21) Dinocap-   (b-28-22) Nickel bis(dimethyldithiocarbamate)-   (b-28-23) Etridiazole (Echlomezol)-   (b-28-24) Oxadixyl-   (b-28-25) Amobam-   (b-28-26) Pyrifenox-   (b-28-27) Oxolinic acid-   (b-28-28) Phosphorous acid-   (b-28-29) Dazomet-   (b-28-30) Methyl isothiocyanate-   (b-28-31) Methasulfocarb-   (b-28-32) 1,3-dichloropropene-   (b-28-33) Carbam (Metam)-   (b-28-34) Methyl iodide (Iodomethane)-   (b-28-35) Sulfur-   (b-28-36) Lime-sulfur mixed agent (Calcium polysulfide)-   (b-28-37) Fentin-   (b-28-38) Sodium hypochlorite-   (b-28-39) Chinomethionat-   (b-28-40) Chloroneb-   (b-28-41) Anilazine-   (b-28-42) Nitrothal-isopropyl-   (b-28-43) Fenitropan-   (b-28-44) Dicloran and-   (b-28-45) Benthiazole (2-(thiocyanatomethylthio)benzothiazole:    TCMTB) as effective ingredients.

Incidentally, in Compound (I), when m is 0, Ym represents a hydrogenatom, and when n is 0, Xn represents a hydrogen atom.

Effects of the Invention

The plant disease control composition of the present invention shows abroad spectrum against various plant pathogens (for example, rice blast(Pyricularia oryzae), gray mold (Botrytis cinerea) of tomato, cucumberand kidney bean, etc.) including fungi and bacteria resistant tochemicals, and shows excellent controlling effects (synergisticcontrolling effects) which could never be expected from a singlecomponent alone. Also, it shows high plant disease controlling effectsagainst existing fungi and bacteria resistant to chemicals, and nochemical damage against plants can be admitted.

BEST MODE TO CARRY OUT THE INVENTION

Respective terms used in Compound (I) in the claims and thespecification of the present application mean, otherwise specificallymentioned, the definition generally used in the field of chemistry andthe definitions described in WO 2005/070917A, JP 2007-1944A, WO2007/011022A and JP 2007-217353A.

In Compound (I) of the present invention, the C₁ to C₆ alkyl portion ofthe “C₁ to C₆ alkyl group” or “C₁ to C₆ alkaneimidoyl group” can be astraight or branched alkyl group having 1 to 6 carbon atoms, forexample, a methyl group, ethyl group, propyl group, isopropyl group,butyl group, isobutyl group, s-butyl group, t-butyl group, pentyl group,isopentyl group, 2-methylbutyl group, neopentyl group, 1-ethylpropylgroup, hexyl group, 4-methylpentyl group, 3-methylpentyl group,2-methylpentyl group, 1-methylpentyl group, 3,3-dimethylbutyl group,2,2-dimethylbutyl group, 1,1-dimethylbutyl group, 1,2-dimethylbutylgroup, 1,3-dimethylbutyl group, 2,3-dimethylbutyl group, 2-ethylbutylgroup, preferably a straight or branched alkyl group having 1 to 5carbon atoms (C₁ to C₅ alkyl group), more preferably a straight orbranched alkyl group having 1 to 4 carbon atoms (C₁ to C₄ alkyl group),further more preferably a straight or branched alkyl group having 1 to 3carbon atoms (C₁ to C₃ alkyl group), particularly preferably a methylgroup, ethyl group or propyl group, most preferably a methyl group orethyl group.

In Compound (I) of the present invention, the “C₂ to C₆ alkenyl group”may be either a straight or branched, and can contain 1 or more optionalnumber of double bond(s), and there may be mentioned, for example, avinyl group, prop-1-en-1-yl group, allyl group, isopropenyl group,but-1-en-1-yl group, but-2-en-1-yl group, but-3-en-1-yl group,2-methylprop-3-en-1-yl group, 1-methylprop-3-en-1-yl group,pent-1-en-1-yl group, pent-2-en-1-yl group, pent-3-en-1-yl group,pent-4-en-1-yl group, 3-methylbut-2-en-1-yl group, 3-methylbut-3-en-1-ylgroup, hex-1-en-1-yl group, hex-2-en-1-yl group, hex-3-en-1-yl group,hex-4-en-1-yl group, hex-5-en-1-yl group or 4-methylpent-3-en-1-ylgroup, preferably a vinyl group, allyl group, iso propenyl group orbut-1-en-1-yl group, more preferably an allyl group or isopropenylgroup.

In Compound (I) of the present invention, the “C₂ to C₆ alkynyl group”may be either a straight or branched, and can contain 1 or more optionalnumber of triple bond(s), and there may be mentioned, for example, anethynyl group, prop-1-yn-1-yl group, prop-2-yn-1-yl group, but-1-yn-1-ylgroup, but-3-yn-1-yl group, 1-methylprop-2-yn-1-yl group, pent-1-yn-1-ylgroup, pent-4-yn-1-yl group, hex-1-yn-1-yl group or hex-5-yn-1-yl group,preferably an ethynyl group or prop-1-yn-1-yl group.

In Compound (I) of the present invention, the “aryl group” may be a C₆to C₁₆ aromatic hydrocarbon group (6 to 16 carbon atoms), and there maybe mentioned, for example, a phenyl group, 1-naphthyl group, 2-naphthylgroup, anthracenyl group, phenanthrenyl group, acenaphthylenyl group,etc., preferably a phenyl group, 1-naphthyl group or 2-naphthyl group,more preferably a phenyl group.

In Compound (I) of the present invention, the “heteroaryl group” may beeither a monocyclic or polycyclic, and may contain 1 or 2 or more sameor different ring-constituting hetero atom(s). A kind of said heteroatom(s) is not particularly limited, and may be mentioned, for example,a nitrogen atom, oxygen atom or sulfur atom. The heteroaryl group may bementioned, for example, a 5- to 7-membered monocyclic heteroaryl groupsuch as a furyl group, thienyl group, pyrrolyl group, oxazolyl group,isoxazolyl group, dihydro isoxazolyl group, thiazolyl group,isothiazolyl group, imidazolyl group, pyrazolyl group, oxadiazolylgroup, thiadiazolyl group, triazolyl group, tetrazolyl group, pyridylgroup, azepinyl group, oxazepinyl group, etc., and the polycyclicheteroaryl group constituting the heteroaryl group may be a 8 to14-membered polycyclic heteroaryl group such as a benzofuranyl group,isobenzofuranyl group, benzothienyl group, indolyl group, isoindolylgroup, indazolyl group, benzoxazolyl group, benzisoxazolyl group,benzothiazolyl group, benzisothiazolyl group, benzoxadiazolyl group,benzothiadiazolyl group, benzotriazolyl group, quinolyl group,isoquinolyl group, cinnolinyl group, quinazolinyl group, quinoxalinylgroup, phthalazinyl group, naphthyridinyl group, purinyl group,pteridinyl group, carbazolyl group, carbolinyl group, acridinyl group,2-acridinyl group, 3-acridinyl group, 4-acridinyl group, 9-acridinylgroup, phenoxazinyl group, phenothiazinyl group, phenadinyl group, etc.,preferably a furyl group, thienyl group, oxazolyl group, pyridyl group,benzofuranyl group or iso benzofuranyl group, more preferably a furylgroup, thienyl group, oxazolyl group or pyridyl group, particularlypreferably a furyl group or thienyl group.

In Compound (I) of the present invention, the “aralkyl group” is a groupin which 1 or 2 or more hydrogen atom(s) (preferably 1 to 3 hydrogenatom(s), more preferably 1 or 2 hydrogen atom(s)) of the above-mentioned“C₁ to C₆ alkyl group” is/are substituted by the above-mentioned “arylgroup”, and there may be mentioned, for example, a benzyl group,1-naphthyl methyl group, 2-naphthyl methyl group, anthracenylmethylgroup, phenanthrenylmethyl group, acenaphthylenylmethyl group,diphenylmethyl group, 1-phenethyl group, 2-phenethyl group,1-(1-naphthyl)ethyl group, 1-(2-naphthyl)ethyl group,2-(1-naphthyl)ethyl group, 2-(2-naphthyl)ethyl group, 3-phenylpropylgroup, 3-(1-naphthyl)propyl group, 3-(2-naphthyl)propyl group,4-phenylbutyl group, 4-(1-naphthyl)butyl group, 4-(2-naphthyl)butylgroup, 5-phenylpentyl group, 5-(1-naphthyl)pentyl group,5-(2-naphthyl)pentyl group, 6-phenylhexyl group, 6-(1-naphthyl)hexylgroup or 6-(2-naphthyl)hexyl group, preferably a benzyl group,diphenylmethyl group, 1-phenethyl group or 2-phenethyl group, morepreferably a benzyl group.

In Compound (I) of the present invention, the “C₃ to C₁₀ cycloalkylring” is, for example, a cyclic hydrocarbon group in which an alkylenegroup having 2 to 9 carbon atoms such as an ethylene group, trimethylenegroup, tetramethylene group, pentamethylene group, hexamethylene group,heptamethylene group, octamethylene group, etc., is bonded to one carbonatom, preferably a cyclic hydrocarbon group (cyclobutyl ring,cyclopentyl ring or cyclohexyl ring) in which it is formed by bonding atrimethylene group, tetramethylene group or pentamethylene group, morepreferably a cyclic hydrocarbon group (cyclohexyl ring) in which it isformed by bonding a pentamethylene group.

In Compound (I) of the present invention, “a halogen atom” is a fluorineatom, chlorine atom, bromine atom or iodine atom, preferably a fluorineatom, chlorine atom or bromine atom, more preferably a fluorine atom orchlorine atom, most preferably a fluorine atom.

In Compound (I) of the present invention, the “C₁ to C₆ alkoxyl group”is a straight or branched alkoxyl group having 1 to 6 carbon atoms, forexample, a methoxy group, ethoxy group, propoxy group, isopropoxy group,butoxy group, isobutoxy group, s-butoxy group, t-butoxy group, pentyloxygroup, isopentyloxy group, 2-methylbutoxy group, neopentyloxy group,1-ethylpropoxy group, hexyloxy group, (4-methylpentyl)-oxy group,(3-methylpentyl)oxy group, (2-methylpentyl)oxy group,(1-methylpentyl)-oxy group, 3,3-dimethylbutoxy group, 2,2-dimethylbutoxygroup, 1,1-dimethylbutoxy group, 1,2-dimethylbutoxy group,1,3-dimethylbutoxy group, 2,3-dimethylbutoxy group, 2-ethylbutoxy group,preferably a straight or branched alkoxyl group having 1 to 4 carbonatoms (C₁ to C₄ alkoxyl group), more preferably a methoxy group, ethoxygroup or isopropoxy group, further more preferably a methoxy group orethoxy group, most preferably a methoxy group.

In Compound (I) of the present invention, the “C₁ to C₆ alkylthio group”is, for example, a straight or branched alkylthio group having 1 to 6carbon atoms such as a methylthio group, ethylthio group, propylthiogroup, isopropylthio group, butylthio group, isopentylthio group,neopentylthio group, 3,3-dimethylbutylthio group, 2-ethylbutylthiogroup, preferably a straight or branched alkylthio group having 1 to 4carbon atoms, more preferably a methylthio group.

In Compound (I) of the present invention, the “acyl group” may bementioned, for example, formyl group, a carbonyl group to which theabove-mentioned “C₁ to C₆ alkyl group” is bound (C₂ to C₇ alkylcarbonylgroup), a carbonyl group to which the above-mentioned “C₂ to C₆ alkenylgroup” is bound (C₃ to C₇ alkenylcarbonyl group), a carbonyl group towhich the above-mentioned “aryl group” is bound (“arylcarbonyl group”),a carbonyl group to which the above-mentioned “C₁ to C₆ alkoxyl group”is bound (C₂ to C₇ alkoxycarbonyl group) or a carbonyl group to whichthe above-mentioned “C₁ to C₆ alkylthio group” is bound (C₂ to C₇alkylthio carbonyl group), preferably a formyl group, C₂ to C₅alkylcarbonyl group, C₃ to C₅ alkenyl carbonyl group, benzoyl group,naphthoyl group, C₂ to C₅ alkoxycarbonyl group or C₂ to C₅ alkylthiocarbonyl group, more preferably a formyl group, C₂ to C₅ alkylcarbonylgroup, benzoyl group or C₂ to C₅ alkoxycarbonyl group, particularlypreferably an acetyl group, methoxycarbonyl group, ethoxycarbonyl groupor benzoyl group, most preferably an acetyl group.

In Compound (I) of the present invention, the “C₂ to C₇ alkoxycarbonylgroup” may be mentioned, for example, an alkoxycarbonyl group having 2to 7 carbon atoms and the alkoxy portion may be straight or branchedsuch as a methoxycarbonyl group, ethoxycarbonyl group, propoxycarbonylgroup, etc., preferably an alkoxycarbonyl group having 2 to 4 carbonatoms, more preferably a methoxycarbonyl group.

In Compound (I) of the present invention, the “C₁ to C₆ alkyl groupwhich may be substituted by the same or different 1 to 3 halogenatom(s)” is, in addition to the above-mentioned “C₁ to C₆ alkyl group”,there may be mentioned, for example, the above-mentioned “C₁ to C₆ alkylgroup” substituted by the same or different 1 to 3 “halogen atom(s)”mentioned above such as a trifluoromethyl group, trichloromethyl group,difluoromethyl group, dichloromethyl group, dibromomethyl group,fluoromethyl group, chloromethyl group, bromomethyl group, iodomethylgroup, 2,2,2-trichloroethyl group, 2,2,2-trifluoroethyl group,2-bromoethyl group, 2-chloroethyl group, 2-fluoroethyl group,3-chloropropyl group, 3,3,3-trifluoropropyl group, 4-fluorobutyl group,3-fluoro-2-methylpropyl group, 3,3,3-trifluoro-2-methylpropyl group,6,6,6-trichlorohexyl group, etc., preferably the above-mentioned “C₁ toC₄ alkyl group” which may be substituted by the same or different 1 to 3“halogen atom(s)” mentioned above, more preferably the above-mentioned“C₁ to C₃ alkyl group” which may be substituted by the same or different1 to 3 “fluorine atom(s) or chlorine atom(s)”, further more preferably amethyl group, ethyl group, propyl group, chloromethyl group ortrifluoromethyl group, particularly preferably a methyl group, ethylgroup or trifluoromethyl group.

In Compound (I) of the present invention, the “N-hydroxy C₁ to C₆alkaneimidoyl group the hydrogen atom of the hydroxyl group of which maybe substituted by the substituent(s) selected from the group consistingof a C₁ to C₆ alkyl group, C₂ to C₆ alkenyl group, C₂ to C₆ alkynylgroup, aralkyl group, aryl group and heteroaryl group” may be mentioned,for example, an N-hydroxyalkaneimidoyl group having 1 to 6 carbon atomssuch as a hydroxyiminomethyl group, N-hydroxyethaneimidoyl group,N-hydroxypropaneimidoyl group and N-hydroxybutaneimidoyl group, and inaddition to the above, a group wherein the hydroxyl group of which issubstituted by the above-mentioned “C₁ to C₆ alkyl group”, theabove-mentioned “C₂ to C₆ alkenyl group”, the above-mentioned “C₂ to C₆alkynyl group”, the above-mentioned “aralkyl group”, the above-mentioned“aryl group” or the above-mentioned “heteroaryl group”, which can be,for example, a methoxyiminomethyl group, N-methoxyethaneimidoyl group,N-ethoxyethaneimidoyl group, N-butoxyethaneimidoyl group,N-allyloxyethaneimidoyl group, N-propargyloxyethaneimidoyl group,N-benzyloxyethaneimidoyl group, N-phenoxyethaneimidoyl group,N-pyridyloxyethaneimidoyl group, N-methoxypropaneimidoyl group,N-methoxybutaneimidoyl group or N-methoxyhexaneimidoyl group, preferablyan N-hydroxyalkaneimidoyl group having 1 to 4 carbon atoms in which thehydrogen atom(s) of the hydroxyl group(s) of which may be substituted bya substituent(s) selected from the group consisting of a C₁ to C₆ alkylgroup and phenyl group, more preferably a hydroxyiminomethyl group,N-hydroxyethaneimidoyl group, methoxyiminomethyl group,N-methoxyethaneimidoyl group or N-ethoxyethaneimidoyl group,particularly preferably a methoxyiminomethyl group orN-methoxyethaneimidoyl group.

In Compound (I) of the present invention, “the C₁ to C₆ alkyl groupwhich may be substituted by the same or different 1 to 3 substituent(s)selected from the group consisting of a halogen atom, C₁ to C₆ alkoxylgroup, C₁ to C₆ alkylthio group and phenoxy group” of R¹, etc., mayinclude, in addition to the above-mentioned “C₁ to C₆ alkyl group whichmay be substituted by the same or different 1 to 3 halogen atom(s)”, forexample, the above-mentioned “C₁ to C₆ alkyl group” substituted by thesame or different 1 to 3 “C₁ to C₆ alkoxyl group(s)” mentioned abovesuch as a methoxymethyl group, ethoxymethyl group, ethoxyethyl group,propoxymethyl group, etc., the above-mentioned “C₁ to C₆ alkyl group”substituted by the same or different 1 to 3 “C₁ to C₆ alkylthiogroup(s)” mentioned above such as a methylthio methyl group,ethylthiomethyl group, ethylthioethyl group, etc., or theabove-mentioned “C₁ to C₆ alkyl group” substituted by the phenoxy groupsuch as a phenoxymethyl group, phenoxyethyl group, etc., and furtherinclude the above-mentioned “C₁ to C₆ alkyl group” substituted by 2 or 3kinds of the substituents selected from the group consisting of theabove-mentioned halogen atom, the above-mentioned C₁ to C₆ alkoxylgroup, the above-mentioned C₁ to C₆ alkylthio group and phenoxy group,such as a 2-methoxy-1-chloroethyl group,3-phenoxy-2-bromo-2-methoxypropyl group,3-phenoxy-2-bromo-2-methylthiopropyl group, etc., preferably a methylgroup, ethyl group, propyl group, methoxymethyl group, ethoxymethylgroup, phenoxymethyl group or methylthiomethyl group, more preferably amethyl group or ethyl group.

In Compound (I) of the present invention, “the C₁ to C₆ alkyl groupwhich may be substituted by the same or different 1 to 3 substituent(s)selected from the group consisting of a halogen atom, C₁ to C₆ alkoxylgroup, hydroxyl group, C₂ to C₇ alkoxycarbonyl group and phenoxy group”of X, etc., may include, in addition to the above-mentioned “C₁ to C₆alkyl group which may be substituted by the same or different 1 to 3halogen atom(s)”, for example, the above-mentioned “C₁ to C₆ alkylgroup” substituted by the same or different 1 to 3 “C₁ to C₆ alkoxylgroup(s)” mentioned above such as a methoxymethyl group, ethoxymethylgroup, ethoxyethyl group, propoxymethyl group, etc., the above-mentioned“C₁ to C₆ alkyl group” substituted by 1 to 3 hydroxyl group(s) such as ahydroxymethyl group, 2-hydroxyethyl group, 3-hydroxypropyl group, etc.,the above-mentioned “C₁ to C₆ alkyl group” substituted by the same ordifferent 1 to 3 “C₂ to C₇ alkoxycarbonyl group(s)” mentioned above suchas a methoxycarbonylmethyl group, ethoxycarbonylmethyl group,2-(methoxycarbonyl)-ethyl group, etc., or the above-mentioned “C₁ to C₆alkyl group” substituted by a phenoxy group(s) such as a phenoxymethylgroup, phenoxyethyl group, etc., and further include the above-mentioned“C₁ to C₆ alkyl group” substituted by 2 or 3 kinds of substituentsselected from the group consisting of the above-mentioned halogen atom,the above-mentioned C₁ to C₆ alkoxyl group, hydroxyl group, theabove-mentioned C₂ to C₇ alkoxycarbonyl group and phenoxy group such asa 2-methoxy-1-chloroethyl group, 2-hydroxy-1-chloroethyl group,3-phenoxy-2-bromo-2-methoxycarbonylpropyl group, etc., preferably amethyl group, ethyl group, propyl group, methoxymethyl group,ethoxymethyl group, phenoxymethyl group, methylthiomethyl group,methoxycarbonylmethyl group or ethoxycarbonylmethyl group, morepreferably a methyl group or ethyl group.

In Compound (I) of the present invention, “the C₂ to C₆ alkenyl groupwhich may be substituted by the same or different 1 to 3 substituent(s)selected from the group consisting of a halogen atom, C₁ to C₆ alkoxylgroup, C₂ to C₇ alkoxycarbonyl group and phenoxy group” of X, etc., mayinclude, in addition to the above-mentioned “C₂ to C₆ alkenyl group”,for example, the above-mentioned “C₂ to C₆ alkenyl group” substituted bythe same or different 1 to 3 halogen atom(s) such as a 3-chloroallylgroup, 4-bromo-2-butenyl group, etc., the above-mentioned “C₂ to C₆alkenyl group” substituted by the same or different 1 to 3 “C₁ to C₆alkoxyl group(s)” mentioned above such as a 3-methoxy-2-propenyl group,4-ethoxy-3-butenyl group, etc., the above-mentioned “C₂ to C₆ alkenylgroup” substituted by the same or different 1 to 3 “C₂ to C₇alkoxycarbonyl group(s)” mentioned above such as a methoxycarbonylvinylgroup, 3-(ethoxycarbonyl)-2-propenyl group,4-(methoxycarbonyl)-2-butenyl group, etc., or the above-mentioned “C₂ toC₆ alkenyl group” substituted by a phenoxy group such as a3-phenoxy-2-butenyl group, etc., and further include the above-mentioned“C₂ to C₆ alkenyl group” substituted by 2 or 3 kinds of substituentsselected from the group consisting of the above-mentioned halogen atom,the above-mentioned C₁ to C₆ alkoxyl group, the above-mentioned C₂ to C₇alkoxycarbonyl group and the phenoxy group such as a4-methoxy-3-chloro-2-butenyl group, 4-methoxycarbonyl-3-chloro-2-butenylgroup, 4-phenoxy-3-chloro-2-butenyl group, etc., preferably a vinylgroup, allyl group, isopropenyl group, but-1-en-1-yl group,3-chloroallyl group, 4-bromo-2-butenyl group, methoxycarbonylvinyl groupor 4-methoxycarbonylbutenyl group, more preferably an allyl group orisopropenyl group.

In Compound (I) of the present invention, “the C₂ to C₆ alkynyl groupwhich may be substituted by the same or different 1 to 3 substituent(s)selected from the group consisting of a halogen atom, C₁ to C₆ alkoxylgroup and phenoxy group” of X, etc., may include, in addition to theabove-mentioned “C₂ to C₆ alkynyl group”, for example, theabove-mentioned “C₂ to C₆ alkynyl group” substituted by the same ordifferent 1 to 3 halogen atom(s) such as a 3-chloro-2-propynyl group,4-bromo-2-butynyl group, etc., the above-mentioned “C₂ to C₆ alkynylgroup” substituted by the same or different 1 to 3 “C₁ to C₆ alkoxylgroup(s)” mentioned above such as a 3-methoxy-2-propynyl group,4-ethoxy-3-butynyl group, etc., or the above-mentioned “C₂ to C₆ alkynylgroup” substituted by a phenoxy group such as a 3-phenoxy-2-butynylgroup, etc., and further include the above-mentioned “C₂ to C₆ alkynylgroup” substituted by 2 or 3 kinds of substituents selected from thegroup consisting of the above-mentioned halogen atom, theabove-mentioned C₁ to C₆ alkoxyl group and the phenoxy group such as a4-methoxy-4-chloro-2-butynyl group, 4-phenoxy-4-chloro-2-butynyl group,etc., preferably an ethynyl group, prop-1-yn-1-yl group,3-chloro-2-propynyl group, 3-methoxy-2-propynyl group,4-methoxy-4-chloro-2-butynyl group or 4-phenoxy-4-chloro-2-butynylgroup, preferably an ethynyl group or prop-1-yn-1-yl group.

In Compound (I) of the present invention, “the amino group which may besubstituted by the same or different 1 or 2 C₁ to C₆ alkyl group(s) oracyl group(s)” of X, etc., may include, in addition to the amino group,the amino group substituted by the same or different 1 or 2 “C₁ to C₆alkyl group(s)” mentioned above or by the same or different 1 or 2 “acylgroup(s)” mentioned above, preferably the amino group substituted by thesame or different 1 or 2 “C₁ to C₄ alkyl group(s)” mentioned above orthe same or different 1 or 2 “acyl group(s)” mentioned above, morepreferably a dimethylamino group, diethylamino group or acetylaminogroup.

In Compound (I) of the present invention, “the C₁ to C₆ alkylidenegroup” formed by R³ and R⁴ in combination, etc., may include, forexample, a straight or branched alkylidene group having 1 to 6 carbonatoms such as a methylidene group (methylene group), ethylidene group,propylidene group, isopropylidene group, preferably a straight orbranched alkylidene group having 1 to 4 carbon atoms, particularlypreferably a methylidene group (methylene group).

In Compound (I) of the present invention, “an aryl group which may besubstituted by the same or different 1 to 6 substituent(s) selected fromthe group consisting of a halogen atom, C₁ to C₆ alkyl group which maybe substituted by the same or different 1 to 3 halogen atom(s), C₁ to C₆alkoxyl group, amino group which may be substituted by the same ordifferent 1 or 2 C₁ to C₆ alkyl group(s) or acyl group(s), nitro group,cyano group, hydroxyl group, mercapto group and C₁ to C₆ alkylthio groupof R¹, etc., may include, in addition to the above-mentioned “arylgroup”, the above-mentioned “aryl group” substituted by the same ordifferent 1 to 6 halogen atom(s) mentioned above, the above-mentioned“aryl group” substituted by the same or different 1 to 6 “C₁ to C₆ alkylgroup(s) which may be substituted by the same or different 1 to 3halogen atom(s)” mentioned above, the above-mentioned “aryl group”substituted by the same or different 1 to 6 “C₁ to C₆ alkoxyl group(s)”mentioned above, the above-mentioned “aryl group” substituted by thesame or different 1 to 6 “amino group(s) which may be substituted by thesame or different 1 or 2 C₁ to C₆ alkyl group(s) or acyl group(s)”mentioned above, the above-mentioned “aryl group” substituted by 1 to 6cyano group(s), the above-mentioned “aryl group” substituted by 1 to 6hydroxyl group(s), the above-mentioned “aryl group” substituted by 1 to6 mercapto group(s) or the above-mentioned “aryl group” substituted bythe same or different 1 to 6 “C₁ to C₆ alkylthio group(s)” mentionedabove, and further includes the above-mentioned “aryl group” substitutedby 2 to 6 substituents selected from the above-mentioned halogen atom,the above-mentioned “C₁ to C₆ alkyl group which may be substituted bythe same or different 1 to 3 halogen atom(s)”, the above-mentioned “C₁to C₆ alkoxyl group”, the above-mentioned “amino group which may besubstituted by the same or different 1 or 2 C₁ to C₆ alkyl group(s) oracyl group(s)”, nitro group, cyano group, hydroxyl group, mercapto groupand the above-mentioned “C₁ to C₆ alkylthio group”, preferably a phenylgroup, 1-naphthyl group, 2-naphthyl group, 4-fluorophenyl group,4-chlorophenyl group, 3-methoxyphenyl group, 3-cyanophenyl group,2-methylthiophenyl group or 2-trifluoromethylphenyl group, morepreferably a phenyl group, 4-fluorophenyl group or 4-chlorophenyl group.

In Compound (I) of the present invention, “a heteroaryl group which maybe substituted by the same or different 1 to 6 substituent(s) selectedfrom the group consisting of a halogen atom, C₁ to C₆ alkyl group whichmay be substituted by the same or different 1 to 3 halogen atom(s) andC₁ to C₆ alkoxyl group” of R¹, etc., may include, in addition to theabove-mentioned “heteroaryl group”, for example, the above-mentioned“heteroaryl group” substituted by the same or different 1 to 6 halogenatom(s), the above-mentioned “heteroaryl group” substituted by the sameor different 1 to 6 the above-mentioned “C₁ to C₆ alkyl group(s) whichmay be substituted by the same or different 1 to 3 halogen atom(s)” orthe above-mentioned “heteroaryl group” substituted by the same ordifferent 1 to 6 “C₁ to C₆ alkoxyl group(s)” mentioned above, furtherincludes the above-mentioned “heteroaryl group” substituted by 2 to 6kinds of substituents selected from the group consisting of theabove-mentioned halogen atom, the above-mentioned “C₁ to C₆ alkyl group”and the above-mentioned “C₁ to C₆ alkoxyl group”, preferably a furylgroup, thienyl group, oxazolyl group, pyridyl group, benzofuranyl group,isobenzofuranyl group, 5-bromofuryl group, 6-chloropyridyl group,4-trifluoromethylpyridyl group, 3-fluorothienyl group or3-methoxythienyl group, more preferably a furyl group or thienyl group.

In Compound (I) of the present invention, “the aralkyl group which maybe substituted by the same or different 1 to 6 substituent(s) selectedfrom the group consisting of a halogen atom, a C₁ to C₆ alkyl groupwhich may be substituted by the same or different 1 to 3 halogenatom(s), a C₁ to C₆ alkoxyl group, an amino group which may besubstituted by the same or different 1 or 2 C₁ to C₆ alkyl group(s) oracyl group(s), a nitro group, a cyano group, a hydroxyl group, amercapto group and a C₁ to C₆ alkylthio group” of R¹, etc., may include,in addition to the above-mentioned “aralkyl group”, the above-mentioned“aralkyl group” substituted by the same or different 1 to 6 halogenatom(s), the above-mentioned “aralkyl group” substituted by the same ordifferent 1 to 6 “C₁ to C₆ alkyl group(s) which may be substituted bythe same or different 1 to 3 halogen atom(s)” mentioned above, theabove-mentioned “aralkyl group” substituted by the same or different 1to 6 “C₁ to C₆ alkoxyl group(s)” mentioned above, the above-mentioned“aralkyl group” substituted by the same or different 1 to 6 “aminogroup(s) which may be substituted by the same or different 1 or 2 C₁ toC₆ alkyl group(s) or acyl group(s)” mentioned above, the above-mentioned“aralkyl group” substituted by 1 to 6 nitro group(s), theabove-mentioned “aralkyl group” substituted by 1 to 6 cyano group(s),the above-mentioned “aralkyl group” substituted by 1 to 6 hydroxylgroup(s), the above-mentioned “aralkyl group” substituted by 1 to 6mercapto group(s) or the above-mentioned “aralkyl group” substituted bythe same or different 1 to 6 “C₁ to C₆ alkylthio group(s)” mentionedabove, further include the above-mentioned “aralkyl group” substitutedby 2 or more substituents selected from the group consisting of theabove-mentioned halogen atom, the above-mentioned “C₁ to C₆ alkyl groupwhich may be substituted by the same or different 1 to 3 halogenatom(s)”, the above-mentioned “C₁ to C₆ alkoxyl group”, theabove-mentioned “amino group which may be substituted by the same ordifferent 1 or 2 C₁ to C₆ alkyl group(s) or acyl group(s)”, a nitrogroup, a cyano group, a hydroxyl group, a mercapto group and theabove-mentioned “C₁ to C₆ alkylthio group”, and when the aralkyl grouphas a substituent(s), the said substituent(s) may be bonded to either ofor both of the aryl ring or the alkyl group constituting the aralkylgroup, preferably a benzyl group, diphenylmethyl group, 1-phenethylgroup, 2-phenethyl group, 4-chlorobenzyl group, 3-cyanobenzyl group or4-methylthio-2-phenethyl group, more preferably a benzyl group.

In Compound (I) of the present invention, “the C₃ to C₁₀ cycloalkyl ringwhich may be substituted by the same or different 1 to 3 substituent(s)selected from the group consisting of a halogen atom, a C₁ to C₆ alkylgroup, a C₁ to C₆ alkoxyl group and a phenoxy group, which is formed incombination with the carbon atoms to which they are bonded” of R¹ andR², etc., may include, in addition to the above-mentioned “C₃ to C₁₀cycloalkyl ring”, for example, the above-mentioned “C₃ to C₁₀ cycloalkylring” substituted by the same or different 1 to 3 halogen atom(s), theabove-mentioned “C₃ to C₁₀ cycloalkyl ring” substituted by the same ordifferent 1 to 3 “C₁ to C₆ alkyl group(s)” mentioned above, theabove-mentioned “C₃ to C₁₀ cycloalkyl ring” substituted by the same ordifferent 1 to 3 “C₁ to C₆ alkoxyl group(s)” mentioned above or theabove-mentioned “C₃ to C₁₀ cycloalkyl ring” substituted by the same ordifferent 1 to 3 phenoxy group(s), further include the above-mentioned“C₃ to C₁₀ cycloalkyl ring” substituted by 2 to 3 kinds of substituentsselected from the group consisting of the above-mentioned halogen atom,the above-mentioned “C₁ to C₆ alkyl group”, the above-mentioned “C₁ toC₆ alkoxyl group” and phenoxy group, preferably a cyclobutyl ring,cyclopentyl ring, cyclohexyl ring, 2-chlorocyclopentyl ring,4-methylcyclohexyl ring, 3-methoxycyclohexyl ring or 3-phenoxycyclohexylring, more preferably a cyclohexyl ring.

In Compound (I) of the present invention, X can be substituted to anoptional substitutable position(s) on the isoquinoline ring with 1 to 4positions, and when Xs exist 2 to 4 (when n is 2 or more), these may bethe same or different from each other.

In Compound (I) of the present invention, Y can be substituted to anoptional substitutable position(s) on the quinoline ring with 1 to 6positions, and when Ys exist 2 to 6 (when m is 2 or more), these may bethe same or different from each other.

Compound (I) in the present invention may be made, for example, amineral acid salt such as a hydrochloride, sulfate, nitrate, etc.: aphosphate; a sulfonate such as a methanesulfonate, ethanesulfonate,benzenesulfonate, p-toluenesulfonate, etc.; or an organic carboxylatesuch as an acetate, benzoate, oxalate, fumarate, salicylate, etc.(preferably a hydrochloride, sulfate, nitrate, methanesulfonate,oxalate, fumarate or salicylate).

Compound (I) and a salt thereof of the present invention may be made asolvate, and these solvates are also contained in the present invention.Such a solvate is preferably a hydrate.

In Compound (I) of the present invention, there is compound having anasymmetric carbon, and in such a case, the present invention includes akind of an optical isomer and a mixture of several kinds of opticalisomers with an optional ratio.

In Compound (I) of the present invention,

R¹ and R² are each

(1a) preferably a C₁ to C₆ alkyl group which may be substituted by thesame or different 1 to 3 halogen atom(s) or phenyl group which may besubstituted by the same or different 1 to 5 halogen atom(s),(1b) more preferably a methyl group, ethyl group, propyl group,trifluoromethyl group, trifluoroethyl group, phenyl group, fluorophenylgroup or chlorophenyl group,

R³ and R⁴ are each

(2a) preferably a hydrogen atom, a halogen atom or a C₁ to C₄ alkylgroup,(2b) more preferably a hydrogen atom, fluorine atom, chlorine atom,methyl group or ethyl group,(2c) further more preferably a hydrogen atom, fluorine atom or methylgroup,

Xn are

(3a) preferably X being a halogen atom; C₁ to C₆ alkyl group; C₂ to C₆alkynyl group; aryl group which may be substituted by the same ordifferent 1 to 6 substituent(s) selected from the group consisting of ahalogen atom, C₁ to C₆ alkyl group which may be substituted by the sameor different 1 to 3 halogen atom(s) and C₁ to C₆ alkoxyl group;heteroaryl group which may be substituted by the same or different 1 to6 substituent(s) selected from the group consisting of a halogen atom,C₁ to C₆ alkyl group which may be substituted by the same or different 1to 3 halogen atom(s) and C₁ to C₆ alkoxyl group; cyano group; or,N-hydroxy-C₁ to C₆ alkaneimidoyl group the hydrogen atom of the hydroxylgroup of which may be substituted by a substituent(s) selected from thegroup consisting of a C₁ to C₆ alkyl group and phenyl group, and n is aninteger of 0 to 2,(3b) more preferably X being a halogen atom; C₁ to C₄ alkyl group; C₂ toC₃ alkynyl group; phenyl group which may be substituted by the same ordifferent 1 or 2 substituents selected from the group consisting of afluorine atom, chlorine atom, C₁ to C₂ alkyl group which may besubstituted by 1 to 3 fluorine atoms and C₁ to C₂ alkoxyl group; furylgroup, thienyl group, oxazolyl group or pyridyl group each of which maybe substituted by the same or different 1 to 3 substituent(s) selectedfrom the group consisting of a fluorine atom, chlorine atom, C₁ to C₂alkyl group which may be substituted by 1 to 3 fluorine atoms and C₁ toC₂ alkoxyl group; cyano group; or, N-hydroxy-C₁ to C₂ alkaneimidoylgroup the hydrogen atom of the hydroxyl group of which may besubstituted by a substituent selected from the group consisting of a C₁to C₂ alkyl group and phenyl group, and n is an integer of 0 to 2,(3c) further more preferably X being a fluorine atom, chlorine atom,bromine atom, methyl group, ethynyl group, furyl group, thienyl group,cyano group, methoxyethaneimidoyl group, ethoxyethaneimidoyl group orphenoxyethaneimidoyl group, and n is 0 or 1,

Ym are

(4a) preferably Y being a fluorine atom, chlorine atom, bromine atom orC₁ to C₃ alkyl group, and m is 0 to 2,(4b) more preferably Y being a fluorine atom, chlorine atom or methylgroup, and m is 0 or 1,(4c) further more preferably Y being a fluorine atom or methyl group,and m is 0 or 1.

Also, a compound in which R¹ and R² are selected from (1a) to (1b), R³and R⁴ are selected from (2a) to (2c), Xn is selected from (3a) to (3c),Ym is selected from (4a) to (4c), and they are combined is suitable, andthere may be mentioned, for example,

(A1) a compound wherein R¹ and R² are each a C₁ to C₆ alkyl group whichmay be substituted by the same or different 1 to 3 halogen atom(s) orphenyl group which may be substituted by the same or different 1 to 5halogen atom(s),

R³ and R⁴ are each a hydrogen atom, halogen atom or C₁ to C₄ alkylgroup,

X is a halogen atom; C₁ to C₆ alkyl group; C₂ to C₆ alkynyl group; arylgroup which may be substituted by the same or different 1 to 6substituent(s) selected from the group consisting of a halogen atom, C₁to C₆ alkyl group which may be substituted by the same or different 1 to3 halogen atom(s) and C₁ to C₆ alkoxyl group; heteroaryl group which maybe substituted by the same or different 1 to 6 substituent(s) selectedfrom the group consisting of a halogen atom, C₁ to C₆ alkyl group whichmay be substituted by the same or different 1 to 3 halogen atom(s) andC₁ to C₆ alkoxyl group; cyano group; or, N-hydroxy-C₁ to C₆alkaneimidoyl group the hydrogen atom of the hydroxyl group of which maybe substituted by a substituent selected from the group consisting of aC₁ to C₆ alkyl group and phenyl group, and n is an integer of 0 to 2,

Y is a fluorine atom, chlorine atom, bromine atom or C₁ to C₃ alkylgroup, and m is 0 to 2,

(A2) a compound wherein R¹ and R² are each a methyl group, ethyl group,propyl group, trifluoromethyl group, trifluoroethyl group, phenyl group,fluorophenyl group or chlorophenyl group,

R³ and R⁴ are each a hydrogen atom, fluorine atom, chlorine atom, methylgroup or ethyl group,

X is a halogen atom; C₁ to C₄ alkyl group; C₂ to C₃ alkynyl group;phenyl group which may be substituted by the same or different 1 or 2substituents selected from the group consisting of a fluorine atom,chlorine atom, C₁ to C₂ alkyl group which may be substituted by 1 to 3fluorine atoms and C₁ to C₂ alkoxyl group; furyl group, thienyl group,oxazolyl group or pyridyl group each of which may be substituted by thesame or different 1 to 3 substituent(s) selected from the groupconsisting of a fluorine atom, chlorine atom, C₁ to C₂ alkyl group whichmay be substituted by 1 to 3 fluorine atoms and C₁ to C₂ alkoxyl group;cyano group; or, N-hydroxy-C₁ to C₂ alkaneimidoyl group the hydrogenatom of the hydroxyl group of which may be substituted by asubstituent(s) selected from the group consisting of a C₁ to C₂ alkylgroup and phenyl group, and n is an integer of 0 to 2,

Y is a fluorine atom, chlorine atom or methyl group, and m is 0 or 1, or

(A3) a compound wherein R¹ and R² are each a methyl group, ethyl group,propyl group, trifluoromethyl group, trifluoroethyl group, phenyl group,fluorophenyl group or chlorophenyl group,

R³ and R⁴ are each a hydrogen atom, fluorine atom or methyl group,

X is a fluorine atom, chlorine atom, bromine atom, methyl group, ethynylgroup, furyl group, thienyl group, cyano group, methoxyethaneimidoylgroup, ethoxyethaneimidoyl group or phenoxyethaneimidoyl group, and n is0 or 1,

Y is a fluorine atom or methyl group, and m is 0 or 1.

Further preferred Compound (I) are

-   (a-1)    3-(5-fluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,-   (a-2)    3-(5-chloro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,-   (a-3) 3-(5-bromo-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,-   (a-4)    3-(5-ethynyl-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,-   (a-5)    3-(5,6-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,-   (a-6)    3-(3-ethyl-5-fluoro-3-propyl-3,4-dihydroisoquinolin-1-yl)quinoline,-   (a-7)    3-(5-fluoro-3-methyl-3-propyl-3,4-dihydroisoquinolin-1-yl)quinoline,-   (a-8)    3-(3-methyl-3-trifluoromethyl-3,4-dihydroisoquinolin-1-yl)quinoline-   (a-9)    3-[3-methyl-3-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-yl]quinoline,-   (a-10) 3-[3-methyl-3-phenyl-3,4-dihydroisoquinolin-1-yl]quinoline,-   (a-11)    3-[3-methyl-3-(4-fluorophenyl)-3,4-dihydroisoquinolin-1-yl]quinoline,-   (a-12)    3-[3-methyl-3-(4-chlorophenyl)-3,4-dihydroisoquinolin-1-yl]quinoline,-   (a-13) 3-(3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline,-   (a-14)    3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline,-   (a-15)    3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)-6-fluoroquinoline,-   (a-16)    3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)-8-fluoroquinoline,-   (a-17)    3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)-8-methylquinoline,-   (a-18)    3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,-   (a-19)    3-(4,5-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline    or-   (a-20)    3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline.

The compounds (I: compound of Group a) in the present invention areknown compounds, and can be prepared by the methods, for example,described in WO 2005/070917 pamphlet or in accordance with thesemethods.

The compound in Group b of the present invention is selected from

(B-1) preferably selected from

Group (1)

a Strobilurin series compound selected from

-   (b-1-1) Azoxystrobin-   (b-1-2) Kresoxim-methyl-   (b-1-3) Pyraclostrobin-   (b-1-4) Picoxystrobin-   (b-1-5) Fluoxastrobin-   (b-1-6) Dimoxystrobin-   (b-1-7) Orysastrobin-   (b-1-8) Metominostrobin and-   (b-1-9) Trifloxystrobin,

Group (2)

a triazole series compound selected from

-   (b-2-1) Simeconazole-   (b-2-2) Tebuconazole-   (b-2-3) Fenbuconazole-   (b-2-4) Hexaconazole-   (b-2-5) Imibenconazole-   (b-2-6) Triadimefon-   (b-2-7) Tetraconazole-   (b-2-8) Prothioconazole-   (b-2-9) Triticonazole-   (b-2-10) Epoxiconazole-   (b-2-11) Ipconazole-   (b-2-12) Metconazole-   (b-2-13) Propiconazole-   (b-2-14) Cyproconazole-   (b-2-15) Difenoconazole-   (b-2-16) Diniconazole-   (b-2-17) Fluquinconazole-   (b-2-18) Flusilazole-   (b-2-19) Penconazole-   (b-2-20) Bromuconazole-   (b-2-21) Triadimenol-   (b-2-22) Flutriafol-   (b-2-23) Myclobutanil-   (b-2-24) Etaconazole and-   (b-2-25) Bitertanol,

Group (3)

an imidazole series compound selected from

-   (b-3-1) Oxpoconazole fumarate-   (b-3-2) Triflumizole-   (b-3-3) Imazalil-   (b-3-4) Imazalil-S-   (b-3-5) Prochloraz-   (b-3-6) Pefurazoate and-   (b-3-7) Triazoxide,

Group (4)

a carboxamide series compound selected from

-   (b-4-1) Penthiopyrad-   (b-4-2) Flutolanil-   (b-4-3) Furametpyr-   (b-4-4) Boscalid-   (b-4-5) Fenhexamid-   (b-4-6) Cyflufenamid-   (b-4-7) Tecloftalam-   (b-4-8) Mandipropamid-   (b-4-9) Bixafen-   (b-4-10) Carboxin-   (b-4-11) Oxycarboxin-   (b-4-12) Mepronil-   (b-4-13) Silthiofam-   (b-4-14) Thifluzamide-   (b-4-15) Flumetover-   (b-4-16) Ethaboxam-   (b-4-17) Zoxamide-   (b-4-18) Tiadinil-   (b-4-19) Isotianil-   (b-4-20) Diclocymet-   (b-4-21) Fenoxanil-   (b-4-22) Fluopicolide-   (b-4-23) Fluopyram-   (b-4-24) Carpropamid-   (b-4-25) Tolfenpyrad-   (b-4-26)    N-[2-(1,3-dimethylbutyl)phenyl]-5-fluoro-1,3-dimethyl-1H-pyrazol-4-carboxamide-   (b-4-27)    N-{2-[1,1′-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1H-pyrazol-4-carboxamide-   (b-4-28)    3-(difluoromethyl)-N-(9-isopropyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)-1-methyl-1H-pyrazol-4-carboxamide-   (b-4-29)    3-(difluoromethyl)-N-[4′-(3,3-dimethylbutyn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazol-4-carboxamide-   (b-4-30)    3-(difluoromethyl)-N-[4′-(3-methoxy-3-methylbutyn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazol-4-carboxamide    and-   (b-4-31)    3-(difluoromethyl)-1-methyl-N-[1,2,3,4-tetrahydro-9-(1-methylethyl)-1,4-methanonaphthalen-5-yl]-1H-pyrazol-4-carboxamide,

Group (5)

an acylalanine series compound selected from

-   (b-5-1) Metalaxyl-   (b-5-2) Metalaxyl-M-   (b-5-3) Benalaxyl-   (b-5-4) Benalaxyl-M and-   (b-5-5) Furalaxyl-M,

Group (6)

a valineamide series compound selected from

-   (b-6-1) Benthiavalicarb-isopropyl and-   (b-6-2) Iprovalicarb;

Group (7)

a sulfoneamide series compound selected from

-   (b-7-1) Cyazofamid-   (b-7-2) Amisulbrom and-   (b-7-3) Flusulfamide,

Group (8)

a sulfenamide series compound selected from

-   (b-8-1) Tolylfluanid and-   (b-8-2) Dichlofluanid,

Group (9)

a carbamate series compound selected from

-   (b-9-1) Propamocarb-   (b-9-2) Propamocarb hydrochloride-   (b-9-3) Diethofencarb and-   (b-9-4) Pyribencarb;

Group (10)

a dithiocarbamate series compound selected from

-   (b-10-1) Mancozeb(Mancozeb)-   (b-10-2) Maneb-   (b-10-3) Propineb-   (b-10-4) Zineb-   (b-10-5) Metiram-   (b-10-6) Ziram-   (b-10-7) Thiuram and-   (b-10-8) Polycarbamate;

Group (11)

a dicarboxylimide series compound selected from

-   (b-11-1) Iprodione-   (b-11-2) Procymidone-   (b-11-3) Captan-   (b-11-4) Vinclozolin-   (b-11-5) Chlozolinate and-   (b-11-6) Folpet;

Group (12)

a guanidine series compound selected from

-   (b-12-1) Iminoctadine trialbesilate-   (b-12-2) Iminoctadine-triacetate-   (b-12-3) Guazatine and-   (b-12-4) Dodine;

Group (13)

a pyrimidine series compound selected from

-   (b-13-1) Mepanipyrim-   (b-13-2) Fenarimol-   (b-13-3) Ferimzone-   (b-13-4) Cyprodinil-   (b-13-5) Pyrimethanil-   (b-13-6) Nuarimol-   (b-13-7) Dimethirimol-   (b-13-8) Bupirimate and-   (b-13-9) Diflumetorim;

Group (14)

a morpholine series compound selected from

-   (b-14-1) Dimethomorph-   (b-14-2) Fenpropimorph-   (b-14-3) Tridemorph-   (b-14-4) Dodemorph and-   (b-14-5) Flumorph;

Group (15)

a benzimidazole series compound selected from

-   (b-15-1) Thiophanate-   (b-15-2) Thiophanate-methyl-   (b-15-3) Benomyl-   (b-15-4) Carbendazim-   (b-15-5) Thiabendazole and-   (b-15-6) Fuberidazole,

Group (16)

a pyrrole series compound selected from

-   (b-16-1) Fludioxonil-   (b-16-2) Fluoroimide and-   (b-16-3) Fenpiclonil;

Group (17)

an organophosphorus series compound selected from

-   (b-17-1) Fosetyl-aluminium-   (b-17-2) Edifenphos-   (b-17-3) Tolclofos-methyl-   (b-17-4) Iprobenfos and-   (b-17-5) Pyrazophos,

Group (18)

a copper series compound selected from

-   (b-18-1) cupric hydroxide-   (b-18-2) copper-   (b-18-3) basic copper chloride-   (b-18-4) basic copper sulfate-   (b-18-5) Oxine-copper-   (b-18-6) copper sulfate pentahydrate-   (b-18-7) anhydrous copper sulfate-   (b-18-8) Copper nonylphenolsulfonate and-   (b-18-9) dodecyl benzene sulfonic acid bis ethylenediamine copper    complex salt,

Group (19)

an antibiotics selected from

-   (b-19-1) Kasugamycin hydrochloride hydrate-   (b-19-2) Validamycin-   (b-19-3) Polyoxins A to N-   (b-19-4) Blastcidin-S benzylamino benzene sulfonate-   (b-19-5) Streptomycin-   (b-19-6) Natamycin-   (b-19-7) Mildiomycin and-   (b-19-8) Oxytetracycline,

Group (20)

an organic chlorine series compound selected from

-   (b-20-1) Chlorothalonil-   (b-20-2) Phthalide and-   (b-20-3) Quintozene,

Group (21)

a triazolopyrimidine series compound selected from

-   (b-21-1)    5-Chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo-[1,5-a]pyrimidine-   (b-21-2)    5-Chloro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine-   (b-21-3)    5-Chloro-N-[(1R)-1,2-dimethylpropyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine-   (b-21-4)    5-(Methoxymethyl)-6-octyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine and-   (b-21-5) 5-Ethyl-6-octyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine,

Group (22)

a benzoyl compound selected from

-   (b-22-1) Metrafenone and-   (b-22-2)    3-(2,3,4-Trimethoxy-6-methylbenzoyl)-5-chloro-2-methoxy-4-methyl    pyridine,

Group (23)

an ethylene diamine series compound selected from

-   (b-23-1)    Isopropyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)-carbamate-   (b-23-2)    Isopropyl((1S)-2,2-dimethyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)-carbamate-   (b-23-3)    Isopropyl((1S)-1-{[(1-benzofuran-2-ylcarbonyl)amino]methyl}-2-methylpropyl)carbamate-   (b-23-4)    2,2,2-Trifluoroethyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}-propyl)carbamate-   (b-23-5)    2,2,2-Trifluoroethyl((1S)-2,2-dimethyl-1-{[(4-methylbenzoyl)amino]methyl}-propyl)carbamate-   (b-23-6)    2,2,2-Trifluoroethyl((1S)-1-{[(1-benzofuran-2-ylcarbonyl)amino]methyl}-2-methylpropyl)carbamate-   (b-23-7) 2,2,2-Trifluoroethyl    {(1S)-1-methyl-2-[(4-methylbenzoyl)amino]ethyl}-carbamate-   (b-23-8)    Benzyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)carbamate    and-   (b-23-9)    Isopropyl((1R)-2,2,2-trifluoro-1-{[(4-methylbenzoyl)amino]methyl}ethyl)-carbamate,

Group (24)

an isoxazolidin series compound selected from

-   (b-24-1)    3-[5-(4-Chlorophenyl)-2,3-dimethylisoxazolidin-3-yl]pyridine and-   (b-24-2)    3-[2,3-Dimethyl-5-(4-methylphenyl)isoxazolidin-3-yl]pyridine and-   (b-24-3)    3-[2-Isopropyl-3-methyl-5-(4-chlorophenyl)isoxazolidin-3-yl]pyridine,

Group (25)

a quinoline series compound selected from

-   (b-25-1) Quinoxyfen-   (b-25-2)    [6-(1,1-Dimethylethyl)-8-fluoro-2,3-dimethylquinolin-4-yl]acetate    and-   (b-25-3)    [6-(1,1-Dimethylethyl)-8-fluoro-2,3-dimethylquinolin-4-yl]methoxyacetate;

Group (26)

a thiazolidine series compound selected from

-   (b-26-1)    (2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2-ylidene]acetonitrile    and-   (b-26-2)    (2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methylphenyl)-1,3-thiazolidin-2-ylidene]acetonitrile,

Group (27)

a pyrazolinone series compound selected from

-   (b-27-1)    1-[(2-Propenylthio)carbonyl]-2-(1-methylethyl)-4-(2-methylphenyl)-5-amino-1H-pyrazol-3-one-   (b-27-2)    1-[(Ethylthio)carbonyl]-2-(1-methylethyl)-4-(2-methylphenyl)-5-amino-1H-pyrazol-3-one    and-   (b-27-3)    1-[(Ethylthio)carbonyl]-2-(1-methylethyl)-4-(2,6-dichlorophenyl)-5-amino-1H-pyrazol-3-one,    and

Group (28)

other fungicides and mildewcides selected from

-   (b-28-1) Hydroxyisoxazol-   (b-28-2) Fluazinam-   (b-28-3) Diclomezine-   (b-28-4) Tricyclazole-   (b-28-5) Cymoxanil-   (b-28-6) Famoxadone-   (b-28-7) Fenamidone-   (b-28-8) Chloropicrin-   (b-28-9) Thiadiazine-   (b-28-10) Proquinazid-   (b-28-11) Spiroxamine-   (b-28-12) Fenpropidin-   (b-28-13) Dithianon-   (b-28-14) Pencycuron-   (b-28-15) Isoprothiolane-   (b-28-16) Probenazole-   (b-28-17) Resveratrol-   (b-28-18) Triforine-   (b-28-19) Acibenzolar-S-methyl-   (b-28-20) Pyroquilon-   (b-28-21) Dinocap-   (b-28-22) Nickel bis(dimethyl dithiocarbamate)-   (b-28-23) Etridiazole-   (b-28-24) Oxadixyl-   (b-28-25) Amobam-   (b-28-26) Pyrifenox-   (b-28-27) Oxolinic acid and-   (b-28-28) Phosphorous acid    (B-2) further preferably selected from

Group (1)

a Strobilurin series compound selected from

-   (b-1-1) Azoxystrobin-   (b-1-2) Kresoxim-methyl-   (b-1-3) Pyraclostrobin-   (b-1-4) Picoxystrobin-   (b-1-5) Fluoxastrobin-   (b-1-6) Dimoxystrobin-   (b-1-7) Orysastrobin-   (b-1-8) Metominostrobin and-   (b-1-9) Trifloxystrobin,

Group (2)

a triazole series compound selected from

-   (b-2-1) Simeconazole-   (b-2-2) Tebuconazole-   (b-2-3) Fenbuconazole-   (b-2-4) Hexaconazole-   (b-2-5) Imibenconazole-   (b-2-6) Triadimefon-   (b-2-7) Tetraconazole-   (b-2-8) Prothioconazole-   (b-2-9) Triticonazole-   (b-2-10) Epoxiconazole-   (b-2-11) Ipconazole-   (b-2-12) Metconazole-   (b-2-13) Propiconazole-   (b-2-14) Cyproconazole-   (b-2-15) Difenoconazole-   (b-2-16) Diniconazole-   (b-2-17) Fluquinconazole and-   (b-2-18) Flusilazole

Group (3)

an imidazole series compound selected from

-   (b-3-1) Oxpoconazole fumarate-   (b-3-2) Triflumizole-   (b-3-3) Imazalil-   (b-3-4) Imazalil-S and-   (b-3-5) Prochloraz

Group (4)

a carboxamide series compound selected from

-   (b-4-1) Penthiopyrad-   (b-4-2) Flutolanil-   (b-4-3) Furametpyr-   (b-4-4) Boscalid-   (b-4-5) Fenhexamid-   (b-4-6) Cyflufenamid-   (b-4-7) Tecloftalam-   (b-4-8) Mandipropamid-   (b-4-9) Bixafen-   (b-4-10) Carboxin-   (b-4-11) Oxycarboxin-   (b-4-12) Mepronil-   (b-4-13) Silthiofam-   (b-4-14) Thifluzamide-   (b-4-15) Flumetover-   (b-4-16) Ethaboxam-   (b-4-17) Zoxamide-   (b-4-18) Tiadinil-   (b-4-19) Isotianil-   (b-4-20) Diclocymet-   (b-4-21) Fenoxanil-   (b-4-22) Fluopicolide-   (b-4-23) Fluopyram-   (b-4-24) Carpropamid-   (b-4-25) Tolfenpyrad-   (b-4-26)    N-[2-(1,3-dimethylbutyl)phenyl]-5-fluoro-1,3-dimethyl-1H-pyrazol-4-carboxamide-   (b-4-27)    N-{2-[1,1′-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1H-pyrazol-4-carboxamide-   (b-4-28)    3-(Difluoromethyl)-N-(9-isopropyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)-1-methyl-1H-pyrazol-4-carboxamide-   (b-4-29)    3-(Difluoromethyl)-N-[4′-(3,3-dimethylbutyn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazol-4-carboxamide    and-   (b-4-30)    3-(Difluoromethyl)-N-[4′-(3-methoxy-3-methylbutyn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazol-4-carboxamide

Group (5)

an acylalanine series compound selected from

-   (b-5-1) Metalaxyl-   (b-5-2) Metalaxyl-M-   (b-5-3) Benalaxyl and-   (b-5-4) Benalaxyl-M

Group (6)

a valineamide series compound selected from

-   (b-6-1) Benthiavalicarb-isopropyl and-   (b-6-2) Iprovalicarb;

Group (7)

a sulfoneamide series compound selected from

-   (b-7-1) Cyazofamid-   (b-7-2) Amisulbrom and-   (b-7-3) Flusulfamide,

Group (8)

a sulfenamide series compound selected from

-   (b-8-1) Tolylfluanid and-   (b-8-2) Dichlofluanid,

Group (9)

a carbamate series compound selected from

-   (b-9-1) Propamocarb-   (b-9-2) Propamocarb hydrochloride-   (b-9-3) Diethofencarb and-   (b-9-4) Pyribencarb;

Group (10)

a dithiocarbamate series compound selected from

-   (b-10-1) Mancozeb-   (b-10-2) Maneb-   (b-10-3) Propineb-   (b-10-4) Zineb-   (b-10-5) Metiram-   (b-10-6) Ziram-   (b-10-7) Thiuram and-   (b-10-8) Polycarbamate;

Group (11)

a dicarboxylimide series compound selected from

-   (b-11-1) Iprodione-   (b-11-2) Procymidone-   (b-11-3) Captan-   (b-11-4) Vinclozolin-   (b-11-5) Chlozolinate and-   (b-11-6) Folpet;

Group (12)

a guanidine series compound selected from

-   (b-12-1) Iminoctadine trialbesilate-   (b-12-2) Iminoctadine-triacetate-   (b-12-3) Guazatine and-   (b-12-4) Dodine;

Group (13)

a pyrimidine series compound selected from

-   (b-13-1) Mepanipyrim-   (b-13-2) Fenarimol-   (b-13-3) Ferimzone-   (b-13-4) Cyprodinil and-   (b-13-5) Pyrimethanil;

Group (14)

a morpholine series compound selected from

-   (b-14-1) Dimethomorph-   (b-14-2) Fenpropimorph-   (b-14-3) Tridemorph-   (b-14-4) Dodemorph and-   (b-14-5) Flumorph;

Group (15)

a benzimidazole series compound selected from

-   (b-15-1) Thiophanate-   (b-15-2) Thiophanate-methyl-   (b-15-3) Benomyl-   (b-15-4) Carbendazim-   (b-15-5) Thiabendazole and-   (b-15-6) Fuberidazole,

Group (16)

a pyrrole series compound selected from

-   (b-16-1) Fludioxonil-   (b-16-2) Fluoroimide and-   (b-16-3) Fenpiclonil;

Group (17)

an organophosphorous series compound selected from

-   (b-17-1) Fosetyl-aluminium-   (b-17-2) Edifenphos and-   (b-17-3) Tolclofos-methyl,

Group (18)

a copper series compound selected from

-   (b-18-1) Cupric hydroxide-   (b-18-2) Copper-   (b-18-3) Basic copper chloride-   (b-18-4) Basic copper sulfate-   (b-18-5) Oxine-copper-   (b-18-6) Copper sulfate pentahydrate and-   (b-18-7) Anhydrous copper sulfate,

Group (19)

an antibiotics selected from

-   (b-19-1) Kasugamycin hydrochloride hydrate-   (b-19-2) Validamycin-   (b-19-3) Polyoxins B and D-   (b-19-4) Blastcidin-S benzylaminobenzene sulfonate, and-   (b-19-5) Streptomycin,

Group (20)

an organic chlorine series compound selected from

-   (b-20-1) Chlorothalonil-   (b-20-2) Phthalide and-   (b-20-3) Quintozene,

Group (21)

a triazolopyrimidine series compound selected from

-   (b-21-1)    5-Chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo-[1,5-a]pyrimidine-   (b-21-2)    5-Chloro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine-   (b-21-3)    5-Chloro-N-[(1R)-1,2-dimethylpropyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine-   (b-21-4)    5-(Methoxymethyl)-6-octyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine and-   (b-21-5) 5-Ethyl-6-octyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine,

Group (22)

a benzoyl compound selected from

-   (b-22-1) Metrafenone and-   (b-22-2)    3-(2,3,4-Trimethoxy-6-methylbenzoyl)-5-chloro-2-methoxy-4-methylpyridine,

Group (23)

an ethylenediamine series compound selected from

-   (b-23-1)    Isopropyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)-carbamate-   (b-23-2)    Isopropyl((1S)-2,2-dimethyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)-carbamate-   (b-23-3)    Isopropyl((1S)-1-{[(1-benzofuran-2-ylcarbonyl)amino]methyl}-2-methylpropyl)carbamate-   (b-23-4)    2,2,2-Trifluoroethyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}-propyl)carbamate-   (b-23-5)    2,2,2-Trifluoroethyl((1S)-2,2-dimethyl-1-{[(4-methylbenzoyl)amino]methyl}-propyl)carbamate-   (b-23-6)    2,2,2-Trifluoroethyl((1S)-1-{[(1-benzofuran-2-ylcarbonyl)amino]methyl}-2-methylpropyl)carbamate-   (b-23-7)    2,2,2-Trifluoroethyl{(1S)-1-methyl-2-[(4-methylbenzoyl)amino]ethyl}-carbamate-   (b-23-8)    Benzyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)carbamate    and-   (b-23-9)    Isopropyl((1R)-2,2,2-trifluoro-1-{[(4-methylbenzoyl)amino]methyl}ethyl)-carbamate,

Group (24)

an isoxazolidine series compound which is

-   (b-24-1) 3-[5-(4-Chloro    phenyl)-2,3-dimethylisoxazolidin-3-yl]pyridine;

Group (25)

a quinoline series compound selected from

-   (b-25-1) Quinoxyfen and-   (b-25-2)    [6-(1,1-Dimethylethyl)-8-fluoro-2,3-dimethylquinoline-4-yl]acetate;

Group (26)

a thiazolidine series compound which is

-   (b-26-1)    (2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2-ylidene]acetonitrile,

Group (27)

a pyrazolinone series compound which is

-   (b-27-1)    1-[(2-Propenylthio)carbonyl]-2-(1-methylethyl)-4-(2-methylphenyl)-5-amino-1H-pyrazol-3-one,    and

Group (28)

other fungicides and mildewcides selected from

-   (b-28-1) Hydroxyisoxazol-   (b-28-2) Fluazinam-   (b-28-3) Diclomezine-   (b-28-4) Tricyclazole-   (b-28-5) Cymoxanil-   (b-28-6) Famoxadone-   (b-28-7) Fenamidone-   (b-28-8) Chloropicrin-   (b-28-9) Thiadiazine-   (b-28-10) Proquinazid-   (b-28-11) Spiroxamine-   (b-28-12) Fenpropidin-   (b-28-13) Dithianon-   (b-28-14) Pencycuron-   (b-28-15) Isoprothiolane-   (b-28-16) Probenazole-   (b-28-17) Resveratrol-   (b-28-18) Triforine-   (b-28-19) Acibenzolar-S-methyl-   (b-28-20) Pyroquilon-   (b-28-21) Dinocap-   (b-28-27) Oxolinic acid and-   (b-28-28) Phosphorous acid,    (B-3) further more preferably selected from

Group (1)

a Strobilurin series compound selected from

-   (b-1-1) Azoxystrobin and-   (b-1-2) Kresoxim-methyl,

Group (2)

a triazole series compound selected from

-   (b-2-1) Simeconazole-   (b-2-2) Tebuconazole-   (b-2-3) Fenbuconazole-   (b-2-4) Hexaconazole-   (b-2-5) Imibenconazole and-   (b-2-6) Triadimefon,

Group (3)

an imidazole series compound selected from

-   (b-3-1) Oxpoconazole fumarate and-   (b-3-2) Triflumizole,

Group (4)

a carboxamide series compound selected from

-   (b-4-1) Penthiopyrad-   (b-4-2) Flutolanil-   (b-4-3) Furametpyr-   (b-4-4) Boscalid-   (b-4-5) Fenhexamid-   (b-4-6) Cyflufenamid and-   (b-4-7) Tecloftalam,

Group (5)

an acylalanine series compound selected from

-   (b-5-1) Metalaxyl-   (b-5-2) Metalaxyl-M-   (b-5-3) Benalaxyl and-   (b-5-4) Benalaxyl-M,

Group (6)

a valineamide series compound which is

-   (b-6-1) Benthiavalicarb-isopropyl,

Group (7)

a sulfoneamide series compound which is

-   (b-7-1) Cyazofamid,

Group (9)

a carbamate series compound selected from

-   (b-9-1) Propamocarb hydrochloride and-   (b-9-2) Diethofencarb,

Group (10)

a dithiocarbamate series compound selected from

-   (b-10-1) Mancozeb and-   (b-10-2) Maneb,

Group (11)

a dicarboxylimide series compound selected from

-   (b-11-1) Iprodione-   (b-11-2) Procymidone and-   (b-11-3) Captan,

Group (12)

a guanidine series compound which is

-   (b-12-1) Iminoctadine trialbesilate,

Group (13)

a pyrimidine series compound selected from

-   (b-13-1) Mepanipyrim-   (b-13-2) Fenarimol and-   (b-13-3) Ferimzone,

Group (14)

a morpholine series compound which is

-   (b-14-1) Dimethomorph,

Group (15)

a benzimidazole series compound which is

-   (b-15-1) Thiophanate-methyl,

Group (16)

a pyrrole series compound which is

-   (b-16-1) Fludioxonil,

Group (18)

a copper series compound which is

-   (b-18-1) cupric hydroxide,

Group (19)

an antibiotics selected from

-   (b-19-1) Kasugamycin hydrochloride hydrate-   (b-19-2) Validamycin, and-   (b-19-3) Polyoxins B and D,

Group (20)

an organic chlorine series compound selected from

-   (b-20-1) Chlorothalonil and-   (b-20-2) Phthalide,

Group (23)

an ethylenediamine series compound selected from

-   (b-23-1)    Isopropyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)-carbamate-   (b-23-2)    Isopropyl((1S)-2,2-dimethyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)-carbamate-   (b-23-3)    Isopropyl((1S)-1-{[(1-benzofuran-2-ylcarbonyl)amino]methyl}-2-methylpropyl)carbamate-   (b-23-4)    2,2,2-Trifluoroethyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}-propyl)carbamate-   (b-23-5)    2,2,2-Trifluoroethyl((1S)-2,2-dimethyl-1-{[(4-methylbenzoyl)amino]methyl}-propyl)carbamate-   (b-23-6)    2,2,2-Trifluoroethyl((1S)-1-{[(1-benzofuran-2-ylcarbonyl)amino]methyl}-2-methylpropyl)carbamate-   (b-23-7)    2,2,2-Trifluoroethyl{(1S)-1-methyl-2-[(4-methylbenzoyl)amino]ethyl}-carbamate-   (b-23-8)    Benzyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)carbamate    and-   (b-23-9)    Isopropyl((1R)-2,2,2-trifluoro-1-{[(4-methylbenzoyl)amino]methyl}ethyl)-carbamate,    and

Group (28)

other fungicides and mildewcides selected from

-   (b-28-2) Fluazinam-   (b-28-3) Diclomezine-   (b-28-4) Tricyclazole-   (b-28-5) Cymoxanil and-   (b-28-6) Famoxadone.

The compounds of Group b in the present invention are known compounds,and they can be prepared by, for example, the methods described in ThePesticide Manual (14th Edition) [British Crop Protection Council Pubn.,2006], WO 1997/15552A, WO 2003/070705A, AGROW No. 243 (1995), WO1999/024413A, WO 2004/016088A, WO 2003/010149A, WO 2003/74491A, WO2004/35589A, WO 2004/58723A, WO 1999/21851A, WO 2001/10825A, WO1998/46607A, JP 2000-119275A, WO 2002/38565A, WO 2006/87325A, WO2005/87773A, WO 2002/02527A, WO 2003/008372A, WO 2005/042474A, WO2007/111024A, JP 2006-282508A, JP 2000-281678A, WO 2001/92231A, JP2000-319270A and JP 2000-226374A or in accordance with these methods.

The plant disease control composition of the present invention givessynergistic controlling effects as compared to the case where eacheffective ingredient is used alone.

The plant disease control composition of the present invention may beused as such, but it is generally used by mixing with a carrier, anddepending on necessity, by adding an auxiliary for preparation such as asurfactant, wetting agent, fixing agent, thickener, antiseptics,colorant, stabilizer, etc., to prepare a wettable powder, flowable,water dispersible granule, dust formulation, emulsifiable concentrate,etc., according to the conventionally known method and used suitably. Acontent of the quinoline compound (I: compound of Group a) as aneffective ingredient in these preparations is generally in the range of0.005 to 99%, preferably in the range of 0.01 to 90%, more preferably inthe range of 0.1 to 85% in a weight ratio. Also, a content of thefungicidal compound of Group b as an effective ingredient in thesepreparations is generally in the range of 0.005 to 99%, preferably inthe range of 0.1 to 90% in a weight ratio, and a sum of the quinolinecompound (I: compound of Group a) and the fungicidal compound of Group bis generally in the range of 0.005 to 99%, preferably in the range of0.01 to 90%, more preferably in the range of 0.1 to 85% in a weightratio. A mixing ratio of the quinoline compound (I: compound of Group a)and the fungicidal compound of Group b is generally 0.01 to 1000 of thefungicidal compound of Group b based on the quinoline compound as 1,preferably 0.1 to 100 of the fungicidal compound of Group b based on thequinoline compound as 1 in a weight ratio.

In the plant disease control composition of the present invention, atotal content of the effective ingredients including the quinolinecompound (I: compound of Group a) and the fungicidal compound of Group bmay vary depending on the form of the preparation, and generally 0.01 to30% by weight in the dust formulation, 0.1 to 80% by weight in thewettable powder, 0.5 to 20% by weight in the granule, 2 to 50% by weightin the emulsifiable concentrate, 1 to 50% by weight in the flowablepreparation, and 1 to 80% by weight in the dry flowable preparation. Itis preferably 0.05 to 10% by weight in the dust formulation, 5 to 60% byweight in the wettable powder, 5 to 20% by weight in the emulsifiableconcentrate, 5 to 50% by weight in the flowable preparation, and 5 to50% by weight in the dry flowable preparation. A content of theauxiliary is 0 to 80% by weight, and a content of the carrier is anamount in which total contents of the compounds of the effectiveingredients and the auxiliary are deducted from 100% by weight.

The carrier to be used in the above-mentioned composition means asynthetic or natural inorganic or organic substance to be formulated forthe purposes of helping the effective ingredients to be reached to theportion to be treated, and making storage, transport and handling of thecompounds of effective ingredients easy. Either of the solid or liquidcarriers may be used so long as it is generally used for agriculturaland horticultural chemicals, and not limited to specific materials. Thesolid carrier may be mentioned, for example, inorganic substancesubstances such as bentonite, montmorillonite, kaolinite, diatomaceousearth, white clay, talc, clay, vermiculite, gypsum, calcium carbonate,amorphous silica, ammonium sulfate, etc.; vegetable organic substancessuch as soybean powder, wood powder, sawdust, wheat powder, lactose,sucrose, glucose, etc.; or urea, etc. The liquid carrier may bementioned, for example, aromatic hydrocarbons and naphthenes such astoluene, xylene, cumene, etc.; paraffin series hydrocarbons such asn-paraffin, iso-paraffin, liquid paraffin, kerosene, mineral oil,polybutene, etc.; ketones such as acetone, methylethyl ketone, etc.;ethers such as dioxane, diethylene glycol dimethyl ether, etc.; alcoholssuch as ethanol, propanol, ethylene glycol, etc.; carbonates such asethylene carbonate, propylene carbonate, butylene carbonate, etc.;aprotic solvents such as dimethylformamide, dimethylsulfoxide, etc.; orwater, etc.

Further, to strengthen the effect of the compounds in the composition ofthe present invention, an auxiliary may be used each singly or incombination depending on the purposes and considering the preparationform of the preparation, treatment methods, etc. As the auxiliary, asurfactant which is generally used for the purpose of emulsifying,dispersing, spreading or/and wetting the agricultural preparation may bementioned, for example, a nonionic surfactant such as a sorbitane fattyacid ester, polyoxyethylene sorbitane fatty acid ester, sucrose fattyacid ester, polyoxyethylene fatty acid ester, polyoxyethylene resin acidester, polyoxyethylene fatty acid diester, polyoxyethylene castor oil,polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether,polyoxyethylene dialkyl phenyl ether, formalin condensate ofpolyoxyethylene alkyl phenyl ether, polyoxyethylene polyoxypropyleneblock polymer, alkyl polyoxyethylene polyoxypropylene block polymerether, alkyl phenyl polyoxyethylene polyoxypropylene block polymerether, polyoxyethylene alkyl amine, polyoxyethylene fatty acidamide,polyoxyethylene bisphenyl ether, polyoxyalkylene benzyl phenyl ether,polyoxyalkylene styrylphenyl ether, polyoxyalkylene adduct of a higheralcohol, and polyoxyethylene ether and ester type silicone and fluorineseries surfactant, etc.; an anionic surfactant such as an alkyl sulfate,polyoxyethylene alkyl ether sulfate, polyoxyethylene alkyl phenyl ethersulfate, polyoxyethylene benzyl phenyl ether sulfate, polyoxyethylenestyrylphenyl ether sulfate, polyoxyethylene polyoxypropylene blockpolymersulfate, paraffin sulfonate, alkanesulfonate, AOS, dialkylsulfosuccinate, alkyl benzene sulfonate, naphthalene sulfonate, dialkylnaphthalene sulfonate, formalin condensate of naphthalene sulfonate,alkyl diphenyl ether disulfonate, lignin sulfonate, polyoxyethylenealkyl phenyl ether sulfonate, polyoxyethylene alkyl ether sulfosuccinicacid half ester, fatty acid salt, N-methyl-fatty acid sarcosinate, resinacid salt, polyoxyethylene alkyl ether phosphate, polyoxyethylene phenylether phosphate, polyoxyethylene dialkylphenyl ether phosphate,polyoxyethylene benzylated phenyl ether phosphate, polyoxyethylenebenzylated phenyl phenyl ether phosphate, polyoxyethylene styrylatedphenyl ether phosphate, polyoxyethylene styrylated phenyl phenyl etherphosphate, polyoxyethylene polyoxypropylene block polymerphosphate,phosphatidylcholine, phosphatidylethanol imine, alkyl phosphate, sodiumtripolyphosphate, etc.; a cationic surfactant such as a polyanion typepolymer surfactant derived from acrylic acid, acrylonitrile andacrylamido methylpropane sulfonic acid, alkyl trimethyl ammoniumchloride, methyl polyoxyethylene alkyl ammonium chloride, alkyl N-methylpyridinium bromide, monomethylated ammonium chloride, dialkyl methylatedammonium chloride, alkyl penta methylpropylene amine dichloride, alkyldimethyl benzalkonium chloride, benzethonium chloride, etc.; or anamphoteric surfactant such as a dialkyl diaminoethyl betaine, alkyldimethyl benzyl betaine, etc. A binder to be used as the auxiliary maybe mentioned, for example, sodium arginate, polyvinyl alcohol, GumArabic, CMC sodium or bentonite, etc., a disintegrator may be mentioned,for example, CMC sodium or croscarmellose sodium sodium, and astabilizer may be mentioned, for example, a hindered phenol seriesantioxidant, or a benzotriazole series or hindered amine series UVabsorber, etc. A pH adjuster may be mentioned, for example, phosphoricacid, acetic acid or sodium hydroxide, and an antifungal and antisepticmay be mentioned, for example, a fungicide for industrial purpose, anantifungal and antiseptic such as 1,2-benzisothiazolin-3-one, etc. Athickening agent may be mentioned, for example, xanthan gum, guar gum,CMC sodium, Gum Arabic, polyvinyl alcohol or montmorillonite, etc. Adefoaming agent may be mentioned, for example, a silicone seriescompound, and an antifreezing agent may be mentioned, for example,propylene glycol or ethylene glycol, etc. However, these auxiliaries arenot limited by the above.

An application method of the composition of the present invention may bementioned, for example, a foliar spray treatment to individual plants,nursery-box treatment, spray treatment onto the soil surface, soilincorporation after spray treatment onto the soil surface, injectiontreatment into the soil, soil incorporation after injection treatmentinto the soil, soil drench, soil incorporation after soil drench, spraytreatment to plant seeds, smear treatment to plant seeds, dip treatmentto plant seeds or powder dressing treatment to plant seeds, etc., andany application methods generally utilized for a person skilled in theart can give sufficient effects.

Also, a method for controlling plant disease in the present inventionincludes methods in which a plant disease control composition containingCompound (I) of Group a and the fungicidal compound of Group b aseffective ingredients is applied, a plant disease control compositioncontaining Compound (I) of Group a as an effective ingredient and aplant disease control composition containing a fungicidal compound ofGroup b as an effective ingredient are simultaneously applied, and,either one of the plant disease control composition containing Compound(I) of Group a as an effective ingredient or a plant disease controlcomposition containing a fungicidal compound of Group b as an effectiveingredient is firstly applied, and then, the other above-mentionedcomposition is applied. An hour(s) (term) after applying either one ofthe plant disease control composition containing Compound (I) of Group aas an effective ingredient or the plant disease control compositioncontaining a fungicidal compound of Group b as an effective ingredientis firstly applied till the other above-mentioned composition is appliedis, for example, 1 minute to 2 weeks after applying either one of whichis applied, preferably 5 minutes to 1 week after applying either one ofwhich is applied, more preferably 10 minutes to 3 days after applyingeither one of which is applied.

Further, the plant disease control composition of the present inventioncan be prepared as a composition containing the quinoline compound (I)and the fungicidal compound of Group b with high concentrations. Thehigh concentration composition can be used as a spreading liquid bydiluting with water. The plant disease control composition of thepresent invention can be also prepared by mixing a compositioncontaining the quinoline compound (I) with a high concentration, and acomposition containing the fungicidal compound of Group b with a highconcentration at the time of use to prepare a mixture. This highconcentration composition can be used as a spreading liquid by dilutingwith water (tank mix method).

In the plant disease control composition containing the quinolinecompound (I) of Group a and the fungicidal compound of Group b aseffective ingredients, its applied amount and a concentration to beapplied may vary depending on the crops to be applied, diseases to becontrolled, degree of occurrence of diseases, preparation form of thecompound, application method and various environmental conditions, etc.,and when it is sprayed, it is generally 50 to 10,000 g per hectare,preferably 100 to 5,000 g per hectare as an amount of effectiveingredients. When the wettable powder, flowable agent or emulsifiableconcentrate is used by diluting with water and spreading, its dilutingratio is generally 5 to 50,000-fold, preferably 10 to 20,000-fold, morepreferably 15 to 10,000-fold. In case of the seed disinfection, anamount of the fungicide mixture to be used is generally 0.001 to 50 g,preferably 0.01 to 10 g per kg of the seeds. When the composition of thepresent invention is applied to individual plants by a foliar spraytreatment, spray treatment to the soil surface, injection treatment intothe soil, or soil drench, the treatment may be carried out afterdiluting the chemical to be used by a suitable carrier with a suitableconcentration. When the composition of the present invention iscontacted to plant seeds, the plant seeds may be dipped into thechemical as such. Also, after diluting the chemical to be used in asuitable carrier with a suitable concentration, the plant seeds may becarried out a dip, powder dressing, spray, or smear treatment. An amountof the preparation to be used for powder dressing, spray or smeartreatment is generally 0.05 to 50% or so based on the weight of the dryplant seeds, preferably 0.1 to 30%, but the amount to be used is notlimited by these ranges, and may vary depending on the form of thepreparation or a kind of plant seeds to be treated. Suitable carriersmay include, for example, liquid carriers including water and organicsolvents such as ethanol, etc.; inorganic substances such as bentonite,montmorillonite, kaolinite, diatomaceous earth, white clay, talc, clay,vermiculite, gypsum, calcium carbonate, amorphous silica, ammoniumsulfate, etc., vegetable organic substances such as soybean powder, woodpowder, sawdust, wheat powder, lactose, sucrose, glucose, etc.: or solidcarriers such as urea, etc., but the present invention is not limited bythese.

The individual plants in present specification are those which live withphotosynthesis without any movement, more specifically, there may bementioned, for example, rice, wheat, barley, corn, grape, apple, pear,peach, yellow peach, persimmon, citrus, soybean, kidney bean,strawberry, potato, cabbage, lettuce, tomato, cucumber, eggplant, watermelon, sugar beet, spinach, field pea, pumpkin, sugarcane, tobacco,green pepper, sweet potato, taro, konnyaku, sugar beet, cotton,sunflower, tulip, chrysanthemum or turf, etc., but the present inventionis not limited by these.

The plant seeds in the present specification are those which storenutrients for embryo plant to germination and to be agriculturally usedfor breeding, more specifically, there may be mentioned, for example,seeds of corn, soybean, cotton, rice, sugar beet, wheat, barley,sunflower, tomato, cucumber, eggplant, spinach, field pea, pumpkin,sugarcane, tobacco, green pepper and canola, etc.; seed tuber of taro,potato, sweet potato, konnyaku, etc.; bulb of edible Lily bulbs, tulip,etc., or seed bulb of scallion, etc.; or plants artificially generatedby operating the gene, etc. Said plants may be mentioned, for example,transformed seeds such as soybean, corn, cotton, etc., to whichherbicidal resistance is provided; rice, tobacco, etc., adapted to coldground; corn, cotton, potato, etc., to which insecticidalsubstance-producing ability is provided, etc., which are not inherentlypresent in natural world, but the present invention is not limited bythese.

The composition of the present invention can be used by mixing with theother agricultural chemicals, soil conditioners or fertilizingsubstances such as insecticides, acaricides, nematocides, herbicides andplant growth controllers, etc., as a matter of course, and also possibleto use as a mixed preparation with these materials. Insecticides may bementioned, for example, phosphorus series insecticides such asphenitrothione, diazinon, pyridaphenthion, chlorpyrifos, malathion,phenthoate, dimethoate, methyl thiometon, prothiofos, DDVP, acephate,salithion, EPN, etc.; carbamate series insecticides such as NAC, MTMC,BPMC, pirimicarb, carbosulfan, methomyl, etc.; pyrethroid seriesinsecticides such as ethofenprox, silafluofen, permethrin, fenvalerate,etc.; neonicotinoid series insecticides such as dinotefuran,clothianidin, nitenpyram, thiamethoxam, imidacloprid, thiacloprid,acetamiprid, etc.; and fipronil and ethiprole, etc., but the presentinvention is not limited by these.

The composition and the controlling method of the present invention areeffective to, for example, the following mentioned plant diseases. Inthe following, specific diseases and its fungi or bacteria to becontrolled by the present invention may be exemplified:

blast (Pyricularia oryzae), sheath blight (Thanatephorus cucumeris),brown spot (Cochliobolus miyabeanus), “Bakanae” disease (Gibberellafujikuroi), seedling blight (Pythium spp., Fusarium spp., Trichodermaspp., Rhizopus spp., Rhizoctonia solanietc.), rice ustilaginoidea virens(Claviceps virens) and smut (Tilletia barelayana) of rice; powderymildew (Erysiphe graminis f. sp. hordei; f. sp. tritici), rust (Pucciniastriiformis; Puccinia graminis, Puccinia recondita, Puccinia hordei),mottle leaf (Pyrenophora graminea), net blotch (Pyrenophora teres),fusarium blight (Fusarium graminearum, Fusarium culmorum, Fusariumavenaceum, Microdochium nivale), snow mould (Typhula incarnata, Typhulaishikariensis, Micronectriella nivalis), loose kernel smut (Ustilagonuda, Ustilago tritici, Ustilago nigra, Ustilago avenae), stinking smut(Tilletia caries, Tilletia pancicii), eye spot (Pseudocercosporellaherpotrichoides), foot rot (Rhizoctonia cerealis), scald (Rhynchosporiumsecalis), leaf blight (Septoria tritici), glume blotch (Leptosphaerianodorum), seedling blight (Fusarium spp., Pythium spp., Rhizoctoniaspp., Septoria nodorum, Pyrenophora spp.), damping off (Gaeumannomycesgraminis), anthracnose (Colletotrichum gramaminicola), ergot (Clavicepspurpurea) and spot blotch (Cochliobolus sativus) of family of wheat;fusarium blight (Fusarium graminearumetc.), seedling blight (Fusariumavenaceum, Penicillium spp, Pythium spp., Rhizoctonia spp), rust(Puccinia sorghi), brown spot (Cochliobolus heterostrophus), smut(Ustilago maydis), anthracnose (Colletotrichum gramaminicola) andNorthern leaf spot (Cochliobolus carbonum) of corn;

downy mildew (Plasmopora viticola), rust (Phakopsora ampelopsidis),powdery mildew (Uncinula necator), anthracnose (Elsinoe ampelina), riperot (Glomerella cingulata), black rot (Guignardia bidwellii), dead arm(Phomopsis viticola), fry speck (Zygophiala jamaicensis), gray mold(Botrytis cinerea), bud blight (Diaporthe medusaea), violet root rot(Helicobasidium mompa) and white root rot (Rosellinia necatrix) of grapevine; powdery mildew (Podosphaera leucotricha), scab (Venturiainaequalis), alternaria blotch (Alternaria alternata (Apple pathotype)),rust (Gymnosporangium yamadae), blossom blight (Monillia mali), valsacanker (Valsa ceratosperma), ring rot (Botryosphaeria berengeriana),anthracnose (Colletotrichum acutatum), fry speck (Zygophialajamaicensis), sooty blotch (Gloeodes pomigena), fruit spot(Mycosphaerella pomi), violet root rot (Helicobasidium mompa), whiteroot rot (Rosellinia necatrix), diaporthe canker (Phomopsis mali,Diaporthe tanakae) and blotch (Diplocarpon mali) of apple; phoma rot(Alternaria alternata (Japanese pear pathotype)), scab (Venturianashicola), rust (Gymnosporangium haraeanum), Physalospora canker(Physalospora piricola) and canker (Diaporthe medusaea, Diaporthe eres)of pear; phytophthora rot (Phytophthora cactorum) of European pear; scab(Cladosporium carpophilum), phomopsis rot (Phomopsis sp.), phytophthorafruit rot (Phytophthora sp.) and anthracnose (Gloeosporium laeticolor)of peach; anthracnose (Glomerella cingulata), young-fruit rot (Moniliniakusanoi) and brown rot (Monilinia fructicola) of cherry; anthracnose(Gloeosporium kaki), angular leaf spot (Cercospora kaki; Mycosphaerellanawae), powdery mildew (Phyllactinia kakikora) of persimmon; melanose(Diaporthe citri), common green mold (Penicillium digitatum), blue mold(Penicillium italicum) and scab (Elsinoe fawcettii) of citrus;

gray mold (Botrytis cinerea) of tomato, cucumber, pulse, strawberry,potato, cabbage, eggplant, lettuce, etc.; stem rot (Sclerotiniasclerotiorum) of tomato, cucumber, bean, strawberry, potato, rape,cabbage, eggplant, lettuce, etc.; seedling blight (Rhizoctonia spp.,Pythium spp., Fusarium spp., Phythophthora spp., Sclerotiniasclerotiorumetc.) of various kinds of vegetables such as tomato,cucumber, bean, Japanese radish, water melon, eggplant, rape, greenpepper, spinach, sugar beet, etc.; downy mildew (Pseudoperonosporacubensis), powdery mildew (Sphaerotheca fuliginea), anthracnose(Colletotrichum lagenarium), gummy stem blight (Didymella bryoniae),fusarium wilt (Fusarium oxysporum) and plytophthora rot (Phytophthoraparasitica, Phytophthora melonis, Phytophthora nicotianae, Phytophthoradrechsleri, Phytophthora capsicietc.) of oriental melon; early blight(Alternaria solani), leaf mold (Cladosporium fulvam), late blight(Phytophthora infestans), fusarium wilt (Fusarium oxysporum), root rot(Pythium myriotylum, Pythium dissotocum) and anthracnose (Colletotrichumphomoides) of tomato; powdery mildew (Sphaerotheca fuligineaetc.), leafmold (Mycovellosiella nattrassii), late blight (Phytophthora infestans)and brown rot (Phytophthora capsici) of eggplant; alternaria leaf spot(Alternaria brassicae) of rapeseed; alternaria leaf spot (Alternariabrassicaeetc.), white spot (Cercosporella brassicae), blackleg(Leptospheria maculans), clubroot (Plasmodiophora brassicae) and downymildew (Peronospora brassicae) of Bras sica vegetables; foot rot(Rhizoctonia solani), yellows (Fusarium oxysporum) of cabbage; bottomrot (Rhizoctonia solani) and yellows (Verticillium dahlie) of Chinesecabbage; rust (Puccinia allii), altenaria leaf spot (Alternaria porri),southern blight (Sclerotium rolfsii. Sclerotium rolfsii) and white tipdisease (Phytophthora porri) of weish onion; purple stain (Cercosporakikuchii), sphaceloma scab (Elsinoe glycinnes), black spot (Diaporthephaseololum), rhizoctonia root rot (Rhizoctonia solani), stem rot(Phytophthora megasperma), downy mildew (Peronospora manshurica), rust(Phakopsora pachyrhizi) and anthracnose (Colletotrichum truncatum) ofsoybean; anthracnose (Colletotrichum lindemuthianum) of kidney bean;leaf spot (Mycosphaerella personatum) and brown leaf spot (Cercosporaarachidicola) of peanuts; powdery mildew (Erysiphe pisi) and downymildew (Peronospora pisi) of pea; downy mildew (Peronospora viciae) andphytophthora rot (Phytophthora nicotianae) of broad bean; early blight(Alternaria solani), black scurf (Rhizoctonia solani), late blight(Phytophthora infestans), silver scurf (Spondylocladium atrovirens), dryspot (Fusarium oxysporum, Fusarium solani) and powdery scab (Spongosporasubterranea) of potato; cercospora leaf spot (Cercospora beticola),downy mildew (Peronospora schachtii), aphanomyces root rot (Aphanomycescochioides) and leaf spot (Phoma batae) of sugar beet; leaf blight(Alternaria dauci) of carrots; powdery mildew (Sphaerotheca humuli),phytophthora rot (Phytophthora nicotianae), anthracnose (Gromerellacingulata) and soft-rotted fruits (Pythium ultimum Trow var. ultimum) ofstrawberry;

net blister blight (Exobasidium reticulatum), white scab (Elsinoeleucospila), anthracnose (Colletotrichum theae-sinensis) and gray blight(Pestalotiopsis longiseta) of green tea; brown spot (Alternariaalternata (Tobacco pathotype)), powdery mildew (Erysiphe cichoracearum),anthracnose (Colletotrichum tabacum) and black shank (Phytophthoraparasitica) of tobacco; damping off (Fusarium oxysporum) of cotton;

sclerotinia rot (Sclerotinia sclerotiorum) of sunflower; black spot(Diplocarpon rosae), powdery mildew (Sphaerotheca pannosa), phytophthorarot (Phytophthora megasperma) and downy mildew (Peronospora sparsa) ofrose; leaf blight (Septoria chrysanthemi-indici), rust (Pucciniahoriana) and phytophthora rot (Phytophthora cactorum) of chrysanthemum;or

brown patch (Rhizoctonia solani), dollar spot (Sclerotinia homoeocarpa),Curvularia leaf blight (Curvularia geniculata), rust (Puccinia zoysiae),Helminthosporium leaf blight (Cochliobolus sp.), scald (Rhynchosporiumsecalis), damping off (Gaeumannomyces graminis), anthracnose(Colletotrichum graminicola), typhula brown snow blight (Typhulaincarnata), typhula black snow blight (Typhula ishikariensis),sclerotinia snow blight (Sclerotinia borealis), fairy rings (Marasmiusoreadesetc.), pythium blight (Pythium aphanidermatumetc.) and blast(Pyricularia oryzae) of turfgrass, but the present invention is notlimited by these.

EXAMPLES

In the following, the present invention is more specifically explainedby referring to Preparation examples and Test examples. However, thepresent invention is not limited only by Preparation examples and Testexamples. Incidentally, all the numerical value of the formulationamounts of the respective components described in the followingPreparation examples mean part(s) by weight.

Compounds A (a-14), B (a-18) and C (a-20) in compound (I: Group a) to beused in the following Preparation examples and Test examples arecompounds of compounds Nos. 1-866, 1-929 and 1-930 in WO 2005/070917,respectively, and described in Examples 114, 177 and 178. Their chemicalstructures are shown in Table 1.

TABLE 1 Compound R¹ R² R³ R⁴ Xn Ym A (a-14) Me Me Me Me 5-F H B (a-18)Me Me F F H H C (a-20) Me Me F F 5-F H

Also, compounds 2001 to 2009 of the fungicidal compounds in Group b tobe used in the following Preparation examples and Test examples arecompounds represented by the formula (II):

and R¹⁶ to R¹⁹ are each as shown in Table 2.

TABLE 2 Compound No. R¹⁶ R¹⁷ R¹⁸ R¹⁹ 2001 (b-23-1) iPr iPr H

2002 (b-23-2) iPr tBu H

2003 (b-23-3) iPr iPr H

2004 (b-23-4) F₃CCH₂ iPr H

2005 (b-23-5) F₃CCH₂ tBu H

2006 (b-23-6) F₃CCH₂ iPr H

2007 (b-23-7) F₃CCH₂ Me H

2008 (b-23-8)

iPr H

2009 (b-23-9) iPr CF₃ H

Preparation Example 1 Wettable Powder (a1-1)

Either one of the compounds (10 parts) among Compounds A, B and C asComponent I (Group a), either one of the following mentioned compounds(added amount) as Component II (Group b), Neogen Powder (0.5 part),Carplex (0.5 part), GOHSENOL (0.2 part), Radiolite (0.8 part) and H finepowder (used as the remainder so that the total became 100 parts) werecrushed and mixed to obtain Wettable powder (a1-1).

Compound (added amount) as Component II (Group b) was Maneb (88 parts),Oxpoconazole fumarate (5 parts), Captan (66 parts), Boscalid (25 parts),Diethofencarb (6 parts), Procymidone (25 parts), Fludioxonil (10 parts),Thiophanate-methyl (35 parts), Fenhexamid (25 parts), Fluazinam (10parts), Iminoctadine trialbesilate (20 parts), Polyoxins complex (10parts), Iprodione (25 parts), Penthiopyrad (5 parts), Simeconazole (5parts), Azoxystrobin (4 parts), Kasugamycin monohydrochloride (1 part),Validamycin (5 parts), Tricyclazole (5 parts), Ferimzone (5 parts),Phthalide (5 parts), Diclomezine (10 parts), Flutolanil (12 parts),Furametpyr (5 parts), Hexaconazole (1 parts), Fenbuconazole (2.2 parts),Tebuconazole (10 parts), Kresoxim-methyl (10 parts), Triadimefon (5parts), Mepanipyrim (10 parts), Imibenconazole (7.5 parts), Cyflufenamid(0.8 parts), Fenarimol (2 parts), Triflumizole (3 parts),Fosetyl-aluminium (80 parts), Cymoxanil (10 parts), cupric hydroxide(27.6 parts), TPN (20 parts), Propamocarb hydrochloride (80 parts),Cyazofamid (4.7 parts), Metalaxyl (5 parts), Ethaboxam (5 parts),Mancozeb (3.7 parts), Famoxadone (5 parts), Benthiavalicarb-isopropyl (5parts), Metalaxyl M (5 parts), Dimethomorph (10 parts) or Compound 2001to 2009 (5 parts).

Preparation Example 2 Wettable Powder (a2-1)

Either one of the compounds (5 parts) among Compounds A, B and C asComponent I (Group a), either one of the compounds mentioned inPreparation example 1 as Component II (Group b), Neogen Powder (0.5part), Carplex (0.5 part), GOHSENOL (0.2 part), Radiolite (0.8 part) andH fine powder (used as the remainder so that the total became 100 parts)were crushed and mixed to obtain Wettable powder (a2-1).

Preparation Example 3 Dust Formulation (b1-1)

Either one of the compounds (2 parts) among Compounds A, B and C asComponent I (Group a), either one of the following mentioned compounds(added amount) as Component II (Group b) and clay (used as the remainderso that the total became 100 parts) were uniformly crushed and mixed toobtain Dust formulation (bl-1).

Compounds (added amount) as Component II (Group b) were Captan (40parts), Boscalid (25 parts), Procymidone (25 parts), Thiophanatemethyl(35 parts), Fluazinam (25 parts), Iminoctadine trialbesilate (15 parts),Polyoxins complex (25 parts), Iprodione (25 parts), Simeconazole (10parts), Flutolanil (5 parts) or Validamycin (0.3 part).

Preparation Example 4 Dust Formulation (b2-1)

Either one of the compounds (10 parts) among Compounds A, B and C asComponent I (Group a), either one of the compounds mentioned inPreparation example 3 as Component II (Group b), flocculant (Driless A:0.3 part), clay (50 parts) and calcium carbonate (used as the remainderso that the total became 100 parts) were mixed, and pulverized by a pinmill to obtain Dust formulation (b2-1).

Preparation Example 5 Flowable (c1)

Either one of the compounds (5 parts) among Compounds A, B and C asComponent I (Group a), either one of the following mentioned compounds(added amount) as Component II, propylene glycol (7 parts), sodiumlignosulfate (4 parts), sodium dioctylsulfosuccinate (2 parts) and water(used as the remainder so that the total became 100 parts) were wetpulverized by a sand grinder to obtain Flowable (c1).

Compounds (added amount) as Component II (Group b) were Azoxystrobin (10parts), Tricyclazole (10 parts), Ferimzone (10 parts), Phthalide (10parts), Flutolanil (3.5 parts), Hexaconazole (10 parts), Fenbuconazole(11 parts), Tebuconazole (10 parts), Procymidone (20 parts), Cyazofamid(4 parts), TPN (20 parts), Iminoctadine trialbesilate (5 parts) orsulfur (30 parts).

Preparation Example 6 Emulsifiable Concentrate (d1-1)

Either one of the compounds (10 parts) among Compounds A, B and C asComponent I (Group a), either one of the following mentioned compounds(added amount) as Component II (Group b), cyclo hexane (10 parts), Tween20 (surfactant: 20 parts) and xylene (used as the remainder so that thetotal became 100 parts) were uniformly dissolved and mixed to obtainEmulsifiable concentrate (d1-1).

Compounds (added amount) as Component II (Group b) were Boscalid (20parts), Procymidone (20 parts), Flutolanil (3.5 parts), Fenbuconazole(11 parts), Tebuconazole (10 parts), Triflumizole (15 parts), TPN (20parts), Ipconazole (10 parts), Polyoxins complex (5 parts),Tetraconazole (10 parts), Triforine (15 parts), Triadimefon (25 parts)or Difenoconazole (25 parts).

Preparation Example 7 Granules (e1-1)

Either one of the compounds (5 parts) among Compounds A, B and C asComponent I (Group a), either one of the following mentioned compounds(added amount) as Component II (Group b), wetting agent (Neopelex No. 6FPowder: 0.5 part), binder (AMICOL No. 1: 3 parts), talc (15 parts) andclay (used as the remainder so that the total became 100 parts) weremixed, hydrolyzed and then, molded by a pellet mill. The obtained moldedproduct was dried and seived to obtain Granules (e1-1).

Compounds (added amount) as Component II (Group b) were Boscalid (25parts), Procymidone (25 parts), Fludioxonil (10 parts), Fenhexamid (25parts), Iminoctadine trialbesilate (15 parts), Penthiopyrad (10 parts),Simeconazole (10 parts), Azoxystrobin (10 parts), Validamycin (2.5parts), Tricyclazole (10 parts), Flutolanil (3.5 parts), Furametpyr (10parts), Tebuconazole (10 parts), Metalaxyl (5 parts), Mancozeb (7parts), Diclocymet (3 parts), Metominostrobin (10 parts), Carpropamid(15 parts), Probenazole (10 parts) or Isoprothiolane (5 parts).

Comparative Preparation Example 1 Wettable Powder (a1-2)

Either one of the compounds (10 parts) among Compounds A, B and C asComponent I (Group a), Neogen Powder (0.2 part), Carplex (0.2 part),GOHSENOL (0.1 part), Radiolite (1 part) and H fine powder (used as theremainder so that the total became 100 parts) were pulverized and mixedto obtain Wettable powder (a1-2).

Comparative Preparation Example 2 Wettable Powder (a2-2)

Either one of the compounds (5 parts) among Compounds A, B and C asComponent I (Group a), Neogen Powder (0.2 part), Carplex (0.2 part),GOHSENOL (0.1 part), Radiolite (1 part) and H fine powder (used as theremainder so that the total became 100 parts) were pulverized and mixedto obtain Wettable powder (a2-2).

Comparative Preparation Example 3 Dust Formulation (b1-2)

Either one of the compounds (2 parts) among Compounds A, B and C asComponent I (Group a) and clay (98 parts) were uniformuly pulverized andmixed to obtain Powder (b1-2).

Comparative Preparation Example 4 Dust Formulation (b2-2)

Either one of the compounds (10 parts) among Compounds A, B and C asComponent I (Group a), flocculant (Driless A: 0.3 part), clay (50parts), calcium carbonate (used as the remainder so that the totalbecame 100 parts) were mixed and pulverized by a pin mill to obtainPowder (b2-2).

Comparative Preparation Example 5 Flowable (c1-1)

Either one of the compounds (5 parts) among Compounds A, B and C asComponent I (Group a), propylene glycol (7 parts), sodium lignosulfate(4 parts), sodium dioctylsulfosuccinate (2 parts) and water (82 parts)were wet pulverized by a sand grinder to obtain Flowable (c1-1).

Comparative Preparation Example 6 Emulsifiable Concentrate (d1-2)

Either one of the compounds (10 parts) among Compounds A, B and C asComponent I (Group a), cyclo hexane (10 parts), xylene (50 parts) andTween 20 (surfactant: used as the remainder so that the total became 100parts) were uniformly dissolved and mixed to obtain Emulsifiableconcentrate (d1-2).

Comparative Preparation Example 7 Granules (e1-2)

Either one of the compounds (5 parts) among Compounds A, B and C asComponent I (Group a), wetting agent (Neopelex No. 6F Powder: 0.5 part),binder (AMICOL No. 1: 3 parts), talc (15 parts) and clay (used as theremainder so that the total became 100 parts) were uniformly mixed,hydrolyzed, and then, molded by a pellet mill. The obtained moldedproduct was dried and seived to obtain Granules (e1-2).

Test Example 1 Tomato Gray Mold Preventive Test Diethofencarb-ResistantStrain

In a greenhouse, tomato (variety: Ohgata-Fukuju) planted in a plasticpot having a diameter of 5 cm was grown to the 2nd to 3rd-leaf stage.Wettable powder prepared according to Preparation example 1 andPreparation example 2 were diluted to a predetermined concentration withwater, and sprayed with a spray gun with 10 ml per 2 pots. After dryingthe chemical liquid, a conidiospore suspension prepared from Botrytiscinerea (Diethofencarb-resistant strain) which had been previouslycultured on a MY medium were inoculated by spraying. After inoculation,the pots were placed in a high-humidity chamber (20 to 22° C.), andafter 2 days, the pots were taken out and controlling effects wereexamined. In the examination, a ratio of lesion area occupied per wholeleaflet of tomato was determined according to the indexes of thefollowing mentioned degree of diseases. Also, from the average degree ofdiseases of each treated district, the control value was calculated fromthe following numerical formula. Incidentally, as a comparison, Wettablepowder prepared according to Comparative preparation example 1 andComparative preparation example 2 were similarly tested, and controllingeffects were examined. The results of the spreading test and thetheoretical value according to the Colby's formula are shown in Table 3.

Index of degree of disease

Index Degree of disease 0 No lesion 1 Lesion area is less than ⅓ ofwhole leaflet 2 Lesion area is ⅓ or more and less than ⅔ of wholeleaflet 3 Lesion area is ⅔ or more of whole leaflet

Incidentally, average values of the each treated district andnon-treated district were used as the degree of diseases.

The control value was calculated from the following formula.

Control value=(1−Ratio of diseased leaflets in the treateddistrict/Ratio of diseased leaflets in the non-treated district)×100

Here, Colby's formula is X=P+Q−P×Q/100, wherein X is a theoretical valueof the control value, P is a control value where a certain chemical isspread alone, and Q is a control value where chemicals to be used incombination are spread in admixture.

TABLE 3 Treatment Effective ingredient in the concentration ControlTheoretical preparation (ppm) value value A + Maneb   10 + 177.5 90 86A + Oxpoconazole fumarate 10 + 10 100 83 A + Captan   10 + 133.3 100 89A + Boscalid 10 + 50 100 86 A + Diethofencarb  10 + 12.5 90 83 A +Procymidone 10 + 50 100 86 A + Fludioxonil 10 + 20 100 94 A +Thiophanate-methyl 10 + 70 100 91 A + Fenhexamid 10 + 50 100 92 A +Fluazinam 10 + 20 100 83 A + Iminoctadine trialbesilate 10 + 40 100 94A + Polyoxins complex 10 + 20 100 93 A + Iprodione 10 + 50 100 94 A +Penthiopyrad 10 + 10 100 89 A + Simeconazole 10 + 10 100 89 B + Maneb  10 + 177.5 100 86 B + Oxpoconazole fumarate 10 + 10 100 83 B + Captan  10 + 133.3 100 89 B + Boscalid 10 + 50 100 86 B + Diethofencarb  10 +12.5 100 83 B + Procymidone 10 + 50 100 86 B + Fludioxonil 10 + 20 10094 B + Thiophanate-methyl 10 + 70 100 91 B + Fenhexamid 10 + 50 100 92B + Fluazinam 10 + 20 95 83 B + Iminoctadine trialbesilate 10 + 40 10094 B + Polyoxins complex 10 + 20 100 93 B + Iprodione 10 + 50 100 94 B +Penthiopyrad 10 + 10 100 89 B + Simeconazole 10 + 10 100 89 C + Maneb  10 + 177.5 95 83 C + Oxpoconazole fumarate 10 + 10 95 80 C + Captan  10 + 133.3 100 87 C + Boscalid 10 + 50 100 83 C + Diethofencarb  10 +12.5 93 80 C + Procymidone 10 + 50 93 83 C + Fludioxonil 10 + 20 100 93C + Thiophanate-methyl 10 + 70 100 89 C + Fenhexamid 10 + 50 100 90 C +Fluazinam 10 + 20 90 80 C + Iminoctadine trialbesilate 10 + 40 100 93C + Polyoxins complex 10 + 20 100 92 C + Iprodione 10 + 50 100 93 C +Penthiopyrad 10 + 10 100 87 C + Simeconazole 10 + 10 98 87 Maneb  177.517 Oxpoconazole fumarate 10 0 Captan  133.3 33 Boscalid 50 17Diethofencarb  12.5 0 Procymidone 50 17 Fludioxonil 20 67Thiophanate-methyl 70 43 Fenhexamid 50 50 Fluazinam 20 0 Iminoctadinetrialbesilate 40 67 Polyoxins complex 20 60 Iprodione 50 67 Penthiopyrad10 33 Simeconazole 10 33 A 10 83 B 10 83 C 10 80

From the results shown in the above-mentioned Table 3, it could beunderstood that synergistic effects could be obtained when Compound A, Bor C and the compound of Group b are used in combination. Incidentally,even when Compound A, B or C and the compound of Group b are used incombination, no chemical damage symptom was admitted in the plantmaterial, tomato (variety: Ohgata-Fukuju).

Test Example 2 Rice Blast Preventive Test

In a greenhouse, rice (variety: Sachikaze) planted in a plastic pothaving a diameter of 5 cm was grown to the 3rd to 4th-leaf stage. Spraywas carried out in the same manner as in Test example 1, and after 3days from the spray, a conidiospore suspension prepared from Pyriculariaoryzae which had been previously cultured on an oatmeal medium wereinoculated by spraying. After inoculation, the pots were placed in ahigh-humidity chamber (20 to 23° C.), and taken out on the next day andtransferred into a greenhouse. Controlling effects were examined after 7days from the inoculation. In the examination, a ratio of lesion areaoccupied per one leaf of rice was determined according to the same indexas in Test example 1, and the control value and the theoretical valueaccording to Colby's formula were similarly calculated. The results areshown in Table 4.

TABLE 4 Treatment Effective ingredient in the concentration ControlTheoretical preparation (ppm) value value A + Azoxystrobin 10 + 8 67 38A + Kasugamycin 10 + 2 50 38 monohydrochloride A + Validamycin  10 + 1050 44 A + Tricyclazole  10 + 10 50 36 A + Ferimzone  10 + 10 60 38 A +Phthalide  10 + 10 60 51 A + Diclomezine  10 + 20 50 44 A + Flutolanil 10 + 25 50 38 A + Furametpyr  10 + 10 60 36 A + Compound 2001 10 + 5 6755 A + Compound 2002 10 + 5 78 55 A + Compound 2003 10 + 5 78 66 A +Compound 2004 10 + 5 97 78 A + Compound 2005 10 + 5 98 78 A + Compound2006 10 + 5 97 78 A + Compound 2007 10 + 5 100 78 A + Compound 2008 10 +5 78 55 A + Compound 2009 10 + 5 100 78 B + Azoxystrobin 10 + 8 90 84B + Kasugamycin 10 + 2 90 84 monohydrochloride B + Validamycin  10 + 1098 86 B + Tricyclazole  10 + 10 98 84 B + Ferimzone  10 + 10 97 84 B +Phthalide  10 + 10 97 88 B + Diclomezine  10 + 20 98 86 B + Flutolanil 10 + 25 98 84 B + Furametpyr  10 + 10 97 84 B + Compound 2001 10 + 5 9689 B + Compound 2002 10 + 5 96 89 B + Compound 2003 10 + 5 98 91 B +Compound 2004 10 + 5 100 94 B + Compound 2005 10 + 5 100 94 B + Compound2006 10 + 5 100 94 B + Compound 2007 10 + 5 100 94 B + Compound 200810 + 5 100 89 B + Compound 2009 10 + 5 100 94 C + Azoxystrobin 10 + 8 9579 C + Kasugamycin 10 + 2 89 79 monohydrochloride C + Validamycin  10 +10 98 82 C + Tricyclazole  10 + 10 95 79 C + Ferimzone  10 + 10 97 79C + Phthalide  10 + 10 97 84 C + Diclomezine  10 + 20 100 82 C +Flutolanil  10 + 25 95 79 C + Furametpyr  10 + 10 97 79 C + Compound2001 10 + 5 95 85 C + Compound 2002 10 + 5 96 85 C + Compound 2003 10 +5 98 89 C + Compound 2004 10 + 5 100 93 C + Compound 2005 10 + 5 100 93C + Compound 2006 10 + 5 100 93 C + Compound 2007 10 + 5 100 93 C +Compound 2008 10 + 5 100 85 C + Compound 2009 10 + 5 100 93 Azoxystrobin8 6.7 Kasugamycin 2 6.7 monohydrochloride Validamycin 10  17Tricyclazole 10  3.3 Ferimzone 10  6.7 Phthalide 10  27 Diclomezine 20 17 Flutolanil 25  6.7 Furametpyr 10  3.3 Compound 2001 5 33 Compound2002 5 33 Compound 2003 5 50 Compound 2004 5 67 Compound 2005 5 67Compound 2006 5 67 Compound 2007 5 67 Compound 2008 5 33 Compound 2009 567 A 10  33 B 10  83 C 10  78

From the results shown in the above-mentioned Table 4, it could beunderstood that synergistic effects could be obtained when Compound A, Bor C and the compound of Group b are used in combination. Incidentally,even when Compound A, B or C and the compound of Group b are used incombination, no chemical damage symptom was admitted in the plantmaterial, rice (variety: Sachikaze).

Test Example 3 Rice Blast Curative Test

In a greenhouse, rice (variety: Sachikaze) planted in a plastic pothaving a diameter of 5 cm was grown to the 3rd to 4th-leaf stage. Aconidiospore suspension prepared from Pyricularia oryzae which had beenpreviously cultured on an oatmeal medium were inoculated by spraying.After inoculation, the pots were placed in a high-humidity chamber (20to 23° C.) and taken out on the next day, and spray was carried out inthe same manner as in Test example 1. After drying the chemical liquid,the pots were transferred into a greenhouse, and controlling effectswere examined after 7 days from the spray. In the examination, a ratioof lesion area occupied per one leaf of rice was determined according tothe same index as in Test example 1, and the control value and thetheoretical value according to Colby's formula were similarlycalculated. The results are shown in Table 5.

TABLE 5 Treatment Effective ingredient in the concentration ControlTheoretical preparation (ppm) value value A + Azoxystrobin 10 + 8  96 79A + Kasugamycin 10 + 2  96 77 monohydrochloride A + Validamycin 10 + 1089 77 A + Tricyclazole 10 + 10 89 77 A + Ferimzone 10 + 10 89 77 A +Phthalide 10 + 10 89 77 A + Diclomezine 10 + 20 89 77 A + Flutolanil10 + 25 89 77 A + Furametpyr 10 + 10 89 77 B + Azoxystrobin 10 + 8  9686 B + Kasugamycin 10 + 2  96 85 monohydrochloride B + Validamycin 10 +10 94 85 B + Tricyclazole 10 + 10 94 85 B + Ferimzone 10 + 10 94 85 B +Phthalide 10 + 10 96 85 B + Diclomezine 10 + 20 96 85 B + Flutolanil10 + 25 94 85 B + Furametpyr 10 + 10 100 87 C + Azoxystrobin 10 + 8  9486 C + Kasugamycin 10 + 2  96 85 monohydrochloride C + Validamycin 10 +10 96 85 C + Tricyclazole 10 + 10 96 85 C + Ferimzone 10 + 10 96 85 C +Phthalide 10 + 10 96 85 C + Diclomezine 10 + 20 91 85 C + Flutolanil10 + 25 91 85 C + Furametpyr 10 + 10 94 87 Azoxystrobin  8 1.8Kasugamycin  2 0 monohydrochloride Validamycin 10 0 Tricyclazole 10 0Ferimzone 10 0 Phthalide 10 0 Diclomezine 20 0 Flutolanil 25 0Furametpyr 10 11 A 10 79 B 10 86 C 10 86

From the results shown in the above-mentioned Table 5, it could beunderstood that synergistic effects could be obtained when Compound A, Bor C and the compound of Group b are used in combination. Incidentally,even when Compound A, B or C and the compound of Group b are used incombination, no chemical damage symptom was admitted in the plantmaterial, rice (variety: Sachikaze).

Test Example 4 Cucumber Powdery Mildew Preventive Test

In a greenhouse, cucumber (variety: Sagamihanpaku) planted in a plasticpot having a diameter of 5 cm was grown to the 3rd to 5th-leaf stage.Spray was carried out in the same manner as in Test example 1, and 3days after the spray, a conidiospore suspension prepared fromSphaerotheca fuliginea were inoculated on the leaf surface. Afterinoculation, the pots were placed in a thermostatic greenhouse (20 to25° C.), and controlling effects were examined after 7 days from theinoculation. In the examination, a ratio of lesion area occupied per oneleaf of cucumber was determined according to the same index as in Testexample 1, and the control value and the theoretical value according toColby's formula were similarly calculated. The results are shown inTable 6.

TABLE 6 Treatment Effective ingredient in the concentration ControlTheoretical preparation (ppm) value value A + Hexaconazole 10 + 2  67 58A + Fenbuconazole  10 + 4.4 75 63 A + Tebuconazole 10 + 20 75 67 A +Simeconazole 10 + 10 67 50 A + Kresoxim-methyl 10 + 20 67 58 A +Triadimefon 10 + 10 67 50 A + Mepanipyrim 10 + 20 60 50 A +Imibenconazole 10 + 15 73 67 A + Cyflufenamid  10 + 1.7 83 67 A +Fenarimol 10 + 4  93 83 A + Triflumizole 10 + 6  83 67 B + Hexaconazole10 + 2  93 67 B + Fenbuconazole  10 + 4.4 83 71 B + Tebuconazole 10 + 20100 73 B + Simeconazole 10 + 10 83 60 B + Kresoxim-methyl 10 + 20 92 67B + Triadimefon 10 + 10 73 60 B + Mepanipyrim 10 + 20 67 60 B +Imibenconazole 10 + 15 83 73 B + Cyflufenamid  10 + 1.7 93 73 B +Fenarimol 10 + 4  92 87 B + Triflumizole 10 + 6  93 73 C + Hexaconazole10 + 2  85 71 C + Fenbuconazole  10 + 4.4 88 74 C + Tebuconazole 10 + 20100 77 C + Simeconazole 10 + 10 88 65 C + Kresoxim-methyl 10 + 20 90 71C + Triadimefon 10 + 10 76 65 C + Mepanipyrim 10 + 20 72 65 C +Imibenconazole 10 + 15 90 77 C + Cyflufenamid  10 + 1.7 100 77 C +Fenarimol 10 + 4  98 88 C + Triflumizole 10 + 6  98 77 Hexaconazole  217 Fenbuconazole   4.4 27 Tebuconazole 20 33 Simeconazole 10 0Kresoxim-methyl 20 17 Triadimefon 10 0 Mepanipyrim 20 0 Imibenconazole15 33 Cyflufenamid   1.7 33 Fenarimol  4 67 Triflumizole  6 33 A 10 50 B10 60 C 10 65

From the results shown in the above-mentioned Table 6, it could beunderstood that synergistic effects could be obtained when Compound A, Bor C and the compound of Group b are used in combination. Incidentally,even when Compound A, B or C and the compound of Group b are used incombination, no chemical damage symptom was admitted in the plantmaterial, cucumber (variety: Sagamihanpaku).

Test Example 5 Cucumber Powdery Mildew Curative Test

In a greenhouse, cucumber (variety: Sagamihanpaku) planted in a plasticpot having a diameter of 5 cm was grown to the 3rd to 5th-leaf stage. Aconidiospore suspension prepared from Sphaerotheca fuliginea wereinoculated on the leaf surface, and the pots were transferred into athermostatic greenhouse (20 to 25° C.). Two days after inoculation,spray was carried out in the same manner as in Test example 1. Afterdrying the chemical liquid, the pots were transferred into athermostatic greenhouse, and controlling effects were examined after 7days from the inoculation. In the examination, a ratio of lesion areaoccupied per one leaf of cucumber was determined according to the sameindex as in Test example 1, and the control value and the theoreticalvalue according to Colby's formula were similarly calculated. Theresults are shown in Table 7.

TABLE 7 Treatment Effective ingredient in the concentration ControlTheoretical preparation (ppm) value value A + Hexaconazole 10 + 2  10092 A + Fenbuconazole  10 + 4.4 100 92 A + Tebuconazole 10 + 20 100 89A + Simeconazole 10 + 10 89 78 A + Kresoxim-methyl 10 + 20 96 89 A +Triadimefon 10 + 10 96 89 A + Mepanipyrim 10 + 20 100 92 A +Imibenconazole 10 + 15 100 92 A + Cyflufenamid  10 + 1.7 100 89 A +Fenarimol 10 + 4  100 93 A + Triflumizole 10 + 6  100 89 B +Hexaconazole 10 + 2  100 93 B + Fenbuconazole  10 + 4.4 100 93 B +Tebuconazole 10 + 20 100 91 B + Simeconazole 10 + 10 100 82 B +Kresoxim-methyl 10 + 20 98 91 B + Triadimefon 10 + 10 100 91 B +Mepanipyrim 10 + 20 100 93 B + Imibenconazole 10 + 15 100 93 B +Cyflufenamid  10 + 1.7 100 91 B + Fenarimol 10 + 4  100 94 B +Triflumizole 10 + 6  100 91 C + Hexaconazole 10 + 2  100 93 C +Fenbuconazole  10 + 4.4 100 93 C + Tebuconazole 10 + 20 100 91 C +Simeconazole 10 + 10 100 82 C + Kresoxim-methyl 10 + 20 97 91 C +Triadimefon 10 + 10 100 91 C + Mepanipyrim 10 + 20 100 93 C +Imibenconazole 10 + 15 100 93 C + Cyflufenamid  10 + 1.7 100 91 C +Fenarimol 10 + 4  100 94 C + Triflumizole 10 + 6  97 91 Hexaconazole  275 Fenbuconazole   4.4 75 Tebuconazole 20 67 Simeconazole 10 33Kresoxim-methyl 20 67 Triadimefon 10 67 Mepanipyrim 20 75 Imibenconazole15 75 Cyflufenamid   1.7 67 Fenarimol  4 78 Triflumizole  6 67 A 10 67 B10 73 C 10 73

From the results shown in the above-mentioned Table 7, it could beunderstood that synergistic effects could be obtained when Compound A, Bor C and the compound of Group b are used in combination. Incidentally,even when Compound A, B or C and the compound of Group b are used incombination, no chemical damage symptom was admitted in the plantmaterial, cucumber (variety: Sagamihanpaku).

Test Example 6 Tomato Late Blight Preventive Test

In a greenhouse, tomato (variety: Ohgata-Fukuju) planted in a plasticpot having a diameter of 5 cm was grown to the 2nd to 3rd-leaf stage.Spray was carried out in the same manner as in Test example 1, and afterdrying the chemical liquid, the pots were transferred into a greenhouse.After 3 days from the spray, a sporangium suspension of Phytophthorainfestans were inoculated by spraying. After inoculation, the pots wereplaced in a high-humidity chamber (20 to 22° C.), transferred into agreenhouse on the next day, and controlling effects were examined after7 days from the inoculation. A ratio of lesion area occupied per oneleaf of tomato was determined according to the same index as in Testexample 1, and the control value and the theoretical value according toColby's formula were similarly calculated. The results are shown inTable 8.

TABLE 8 Treatment Effective ingredient in the concentration ControlTheoretical preparation (ppm) value value A + Fosetyl-aluminium  10 +160 17 8.3 A + Cymoxanil 10 + 20 75 50 A + cupric hydroxide  10 + 55.333 17 A + TPN 10 + 40 17 0 A + Propamocarb hydrochloride  10 + 160 17 0A + Cyazofamid  10 + 9.4 100 92 A + Metalaxyl 10 + 10 67 58 A +Ethaboxam 10 + 10 93 83 A + Mancozeb  10 + 7.5 83 67 A + Famoxadone 10 +10 33 17 A + Azoxystrobin 10 + 8  83 67 A + Benthiavalicarb-isopropyl10 + 10 93 80 A + Metalaxyl M 10 + 10 42 33 A + Dimethomorph 10 + 20 7550 B + Fosetyl-aluminium  10 + 160 33 8.3 B + Cymoxanil 10 + 20 100 50B + cupric hydroxide  10 + 55.3 33 17 B + TPN 10 + 40 40 0 B +Propamocarb hydrochloride  10 + 160 33 0 B + Cyazofamid  10 + 9.4 100 92B + Metalaxyl 10 + 10 83 58 B + Ethaboxam 10 + 10 97 83 B + Mancozeb 10 + 7.5 83 67 B + Famoxadone 10 + 10 33 17 B + Azoxystrobin 10 + 8  8367 B + Benthiavalicarb-isopropyl 10 + 10 100 80 B + Metalaxyl M 10 + 1067 33 B + Dimethomorph 10 + 20 83 50 C + Fosetyl-aluminium  10 + 160 178.3 C + Cymoxanil 10 + 20 92 50 C + cupric hydroxide  10 + 55.3 33 17C + TPN 10 + 40 33 0 C + Propamocarb hydrochloride  10 + 160 17 0 C +Cyazofamid  10 + 9.4 100 92 C + Metalaxyl 10 + 10 75 58 C + Ethaboxam10 + 10 92 83 C + Mancozeb  10 + 7.5 83 67 C + Famoxadone 10 + 10 33 17C + Azoxystrobin 10 + 8  83 67 C + Benthiavalicarb-isopropyl 10 + 10 9280 C + Metalaxyl M 10 + 10 67 33 C + Dimethomorph 10 + 20 70 50Fosetyl-aluminium 160  8.3 Cymoxanil 20 50 cupric hydroxide  55.3 17 TPN40 0 Propamocarb hydrochloride 160  0 Cyazofamid   9.4 92 Metalaxyl 1058 Ethaboxam 10 83 Mancozeb   7.5 67 Famoxadone 10 17 Azoxystrobin  8 67Benthiavalicarb-isopropyl 10 80 Metalaxyl M 10 33 Dimethomorph 20 50 A10 0 B 10 0 C 10 0

From the results shown in the above-mentioned Table 8, it could beunderstood that synergistic effects could be obtained when Compound A, Bor C and the compound of Group b are used in combination. Incidentally,even when Compound A, B or C and the compound of Group b are used incombination, no chemical damage symptom was admitted in the plantmaterial, tomato (variety: Ohgata-Fukuju).

Test Example 7 Tomato Late Blight Curative Test

In a greenhouse, tomato (variety: Ohgata-Fukuju) planted in a plasticpot having a diameter of 5 cm was grown to the 2nd to 3rd-leaf stage. Asporangium suspension of Phytophthora infestans were inoculated, thepots were placed in a high-humidity chamber (20 to 22° C.), and takenout on the next day and spray was carried out in the same manner as inTest example 1. After drying the chemical liquid, the pots weretransferred into a greenhouse, and controlling effects were examinedafter 7 days from the inoculation. A ratio of lesion area occupied perone leaf of tomato was determined according to the same index as in Testexample 1, and the control value and the theoretical value according toColby's formula were similarly calculated. The results are shown inTable 9.

TABLE 9 Treatment Effective ingredient in the concentration ControlTheoretical preparation (ppm) value value A + Fosetyl-aluminium  10 +160 33 25 A + Cymoxanil 10 + 20 83 67 A + cupric hydroxide  10 + 55.3 170 A + TPN 10 + 40 6.7 0 A + Propamocarb hydrochloride  10 + 160 33 0 A +Cyazofamid  10 + 9.4 33 0 A + Metalaxyl 10 + 10 76 67 A + Ethaboxam 10 +10 76 67 A + Mancozeb  10 + 7.5 6.7 0 A + Famoxadone 10 + 10 17 0 A +Azoxystrobin 10 + 8  6.7 0 A + Benthiavalicarb-isopropyl 10 + 10 70 67A + Metalaxyl M 10 + 10 20 17 A + Dimethomorph 10 + 20 13 0 B +Fosetyl-aluminium  10 + 160 37 25 B + Cymoxanil 10 + 20 92 67 B + cuprichydroxide  10 + 55.3 33 0 B + TPN 10 + 40 33 0 B + Propamocarbhydrochloride  10 + 160 33 0 B + Cyazofamid  10 + 9.4 33 0 B + Metalaxyl10 + 10 83 67 B + Ethaboxam 10 + 10 83 67 B + Mancozeb  10 + 7.5 17 0B + Famoxadone 10 + 10 17 0 B + Azoxystrobin 10 + 8  17 0 B +Benthiavalicarb-isopropyl 10 + 10 83 67 B + Metalaxyl M 10 + 10 33 17B + Dimethomorph 10 + 20 33 0 C + Fosetyl-aluminium  10 + 160 33 25 C +Cymoxanil 10 + 20 73 67 C + cupric hydroxide  10 + 55.3 33 0 C + TPN10 + 40 33 0 C + Propamocarb hydrochloride  10 + 160 33 0 C + Cyazofamid 10 + 9.4 33 0 C + Metalaxyl 10 + 10 76 67 C + Ethaboxam 10 + 10 83 67C + Mancozeb  10 + 7.5 17 0 C + Famoxadone 10 + 10 17 0 C + Azoxystrobin10 + 8  17 0 C + Benthiavalicarb-isopropyl 10 + 10 92 67 C + Metalaxyl M10 + 10 67 17 C + Dimethomorph 10 + 20 33 0 Fosetyl-aluminium 160  25Cymoxanil 20 67 cupric hydroxide  55.3 0 TPN 40 0 Propamocarbhydrochloride 160  0 Cyazofamid   9.4 0 Metalaxyl 10 67 Ethaboxam 10 67Mancozeb   7.5 0 Famoxadone 10 0 Azoxystrobin  8 0Benthiavalicarb-isopropyl 10 67 Metalaxyl M 10 17 Dimethomorph 20 0 A 100 B 10 0 C 10 0

From the results shown in the above-mentioned Table 9, it could beunderstood that synergistic effects could be obtained when Compound A, Bor C and the compound of Group b are used in combination. Incidentally,even when Compound A, B or C and the compound of Group b are used incombination, no chemical damage symptom was admitted in the plantmaterial, tomato (variety: Ohgata-Fukuju).

Test Example 8 Cucumber Downy Mildew Preventive Test

In a greenhouse, cucumber (variety: Sagamihanpaku) planted in a plasticpot having a diameter of 5 cm was grown to the 3rd to 5th-leaf stage.Spray was carried out in the same manner as in Test example 1, and afterdrying the chemical liquid, the pots were transferred into a greenhouse.After 3 days from the spray, a sporangium suspension ofPseudoperonospora cubensis were inoculated. After inoculation, the potswere placed in a high-humidity chamber (20 to 25° C.), transferred intoa greenhouse on the next day, and controlling effects were examinedafter 7 days from the inoculation. A ratio of lesion area occupied perone leaf of cucumber was determined according to the same index as inTest example 1, and the control value and the theoretical valueaccording to Colby's formula were similarly calculated. The results areshown in Table 10.

TABLE 10 Treatment Effective ingredient in the concentration ControlTheoretical preparation (ppm) value value A + Fosetyl-aluminium  10 +160 80 68 A + Cymoxanil 10 + 20 80 68 A + cupric hydroxide  10 + 55.3 6052 A + TPN 10 + 40 100 68 A + Propamocarb hydrochloride  10 + 160 80 36A + Cyazofamid  10 + 9.4 80 52 A + Metalaxyl 10 + 10 100 68 A +Ethaboxam 10 + 10 80 36 A + Mancozeb  10 + 7.5 100 68 A + Famoxadone10 + 10 60 4 A + Azoxystrobin 10 + 8  80 68 A +Benthiavalicarb-isopropyl 10 + 10 100 52 A + Metalaxyl M 10 + 10 100 68A + Dimethomorph 10 + 20 100 68 B + Fosetyl-aluminium  10 + 160 92 71B + Cymoxanil 10 + 20 100 71 B + cupric hydroxide  10 + 55.3 100 57 B +TPN 10 + 40 100 71 B + Propamocarb hydrochloride  10 + 160 60 42 B +Cyazofamid  10 + 9.4 100 57 B + Metalaxyl 10 + 10 100 71 B + Ethaboxam10 + 10 100 42 B + Mancozeb  10 + 7.5 100 71 B + Famoxadone 10 + 10 10014 B + Azoxystrobin 10 + 8  100 71 B + Benthiavalicarb-isopropyl 10 + 10100 57 B + Metalaxyl M 10 + 10 100 71 B + Dimethomorph 10 + 20 80 71 C +Fosetyl-aluminium  10 + 160 95 73 C + Cymoxanil 10 + 20 95 73 C + cuprichydroxide  10 + 55.3 100 60 C + TPN 10 + 40 100 73 C + Propamocarbhydrochloride  10 + 160 71 46 C + Cyazofamid  10 + 9.4 100 60 C +Metalaxyl 10 + 10 100 73 C + Ethaboxam 10 + 10 100 46 C + Mancozeb  10 +7.5 100 73 C + Famoxadone 10 + 10 100 33 C + Azoxystrobin 10 + 8  100 73C + Benthiavalicarb-isopropyl 10 + 10 100 60 C + Metalaxyl M 10 + 10 10073 C + Dimethomorph 10 + 20 80 73 Fosetyl-aluminium 160  60 Cymoxanil 2060 cupric hydroxide  55.3 40 TPN 40 60 Propamocarb hydrochloride 160  20Cyazofamid   9.4 40 Metalaxyl 10 60 Ethaboxam 10 20 Mancozeb   7.5 60Famoxadone 10 0 Azoxystrobin  8 60 Benthiavalicarb-isopropyl 10 40Metalaxyl M 10 60 Dimethomorph 20 60 A 10 20 B 10 28 C 10 33

From the results of the above-mentioned Table 10, it could be understoodthat synergistic effects could be obtained when Compound A, B or C andthe compound of Group b are used in combination. Incidentally, even whenCompound A, B or C and the compound of Group b are used in combination,no chemical damage symptom was admitted in the plant material, cucumber(variety: Sagamihanpaku).

Test Example 9 Cucumber Downy Mildew Curative Test

In a greenhouse, cucumber (variety: Sagamihanpaku) planted in a plasticpot having a diameter of 5 cm was grown to the 3rd to 5th-leaf stage. Asporangium suspension of Pseudoperonospora cubensis were inoculated, thepots were placed in a high-humidity chamber (20 to 22° C.) and taken outon the next day, and spray was carried out in the same manner as in Testexample 1. After drying the chemical liquid, the pots were transferredinto a greenhouse, and controlling effects were examined after 7 daysfrom the inoculation. A ratio of lesion area occupied per one leaf ofcucumber was determined according to the same index as in Test example1, and the control value and the theoretical value according to Colby'sformula were similarly calculated. The results are shown in Table 11.

TABLE 11 Treatment Effective ingredient in the concentration ControlTheoretical preparation (ppm) value value A + Fosetyl-aluminium  10 +160 92 72 A + Cymoxanil 10 + 20 73 72 A + cupric hydroxide  10 + 55.3 9258 A + TPN 10 + 40 93 86 A + Propamocarb hydrochloride  10 + 160 92 17A + Cyazofamid  10 + 9.4 78 72 A + Metalaxyl 10 + 10 100 93 A +Ethaboxam 10 + 10 83 72 A + Mancozeb  10 + 7.5 87 72 A + Famoxadone 10 +10 100 93 A + Azoxystrobin 10 + 8  100 93 A + Benthiavalicarb-isopropyl10 + 10 92 72 A + Metalaxyl M 10 + 10 100 86 A + Dimethomorph 10 + 20 7558 B + Fosetyl-aluminium  10 + 160 92 78 B + Cymoxanil 10 + 20 92 78 B +cupric hydroxide  10 + 55.3 97 67 B + TPN 10 + 40 97 89 B + Propamocarbhydrochloride  10 + 160 100 33 B + Cyazofamid  10 + 9.4 93 78 B +Metalaxyl 10 + 10 100 94 B + Ethaboxam 10 + 10 93 78 B + Mancozeb  10 +7.5 87 78 B + Famoxadone 10 + 10 100 94 B + Azoxystrobin 10 + 8  100 94B + Benthiavalicarb-isopropyl 10 + 10 100 78 B + Metalaxyl M 10 + 10 10089 B + Dimethomorph 10 + 20 100 67 C + Fosetyl-aluminium  10 + 160 93 78C + Cymoxanil 10 + 20 92 78 C + cupric hydroxide  10 + 55.3 97 67 C +TPN 10 + 40 97 89 C + Propamocarb hydrochloride  10 + 160 100 33 C +Cyazofamid  10 + 9.4 93 78 C + Metalaxyl 10 + 10 100 94 C + Ethaboxam10 + 10 93 78 C + Mancozeb  10 + 7.5 87 78 C + Famoxadone 10 + 10 100 94C + Azoxystrobin 10 + 8  100 94 C + Benthiavalicarb-isopropyl 10 + 10100 78 C + Metalaxyl M 10 + 10 100 89 C + Dimethomorph 10 + 20 100 67Fosetyl-aluminium 160  67 Cymoxanil 20 67 cupric hydroxide  55.3 50 TPN40 83 Propamocarb hydrochloride 160  0 Cyazofamid   9.4 67 Metalaxyl 1092 Ethaboxam 10 67 Mancozeb   7.5 67 Famoxadone 10 92 Azoxystrobin  8 92Benthiavalicarb-isopropyl 10 67 Metalaxyl M 10 83 Dimethomorph 20 50 A10 17 B 10 33 C 10 33

From the results shown in the above-mentioned Table 11, it could beunderstood that synergistic effects could be obtained when Compound A, Bor C and the compound of Group b are used in combination. Incidentally,even when Compound A, B or C and the compound of Group b are used incombination, no symptom of chemical damage was admitted in the plantmaterial, cucumber (variety: Sagamihanpaku).

UTILIZABILITY IN INDUSTRY

The plant disease control composition of the present invention showed abroad spectrum against various plant pathogens (for example, rice blast(Pyricularia oryzae), and gray mold (Botrytis cinerea) of tomato,cucumber and kidney bean, etc.) including fungi and bacteria resistantto chemicals, and shows excellent controlling effects (synergisticcontrolling effects) which could never be expected from a singlecomponent alone. Also, it shows high plant disease controlling effectsagainst existing fungi and bacteria resistant to chemicals, and nochemical damage against plants can be admitted so that it can be used asan excellent plant disease controlling agent.

1. A plant disease control composition comprising (Group a) (a) at leastone quinoline compound selected from the group consisting of (a-14)3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline,(a-18)3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, and(a-20)3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,or a salt thereof, and (Group b) (b) at least one fungicidal compoundselected from the group consisting of Groups (1) to (3) and (5) to (28)below: Group (1) a Strobilurin series compound selected from (b-1-1)Azoxystrobin (b-1-2) Kresoxim-methyl (b-1-3) Pyraclostrobin (b-1-4)Picoxystrobin (b-1-5) Fluoxastrobin (b-1-6) Dimoxystrobin (b-1-7)Orysastrobin (b-1-8) Metominostrobin and (b-1-9) Trifloxystrobin Group(2) a triazole series compound selected from (b-2-1) Simeconazole(b-2-2) Tebuconazole (b-2-3) Fenbuconazole (b-2-4) Hexaconazole (b-2-5)Imibenconazole (b-2-6) Triadimefon (b-2-7) Tetraconazole (b-2-8)Prothioconazole (b-2-9) Triticonazole (b-2-10) Epoxiconazole (b-2-11)Ipconazole (b-2-12) Metconazole (b-2-13) Propiconazole (b-2-14)Cyproconazole (b-2-15) Difenoconazole (b-2-16) Diniconazole (b-2-17)Fluquinconazole (b-2-18) Flusilazole (b-2-19) Penconazole (b-2-20)Bromuconazole (b-2-21) Triadimenol (b-2-22) Flutriafol (b-2-23)Myclobutanil (b-2-24) Etaconazole and (b-2-25) Bitertanol Group (3) animidazole series compound selected from (b-3-1) Oxpoconazole fumarate(b-3-2) Triflumizole (b-3-3) Imazalil (b-3-4) Imazalil-S (b-3-5)Prochloraz (b-3-6) Pefurazoate and (b-3-7) Triazoxide Group (5) anacylalanine series compound selected from (b-5-1) Metalaxyl (b-5-2)Metalaxyl-M (b-5-3) Benalaxyl (b-5-4) Benalaxyl-M and (b-5-5)Furalaxyl-M Group (6) a valineamide series compound selected from(b-6-1) Benthiavalicarb-isopropyl and (b-6-2) Iprovalicarb Group (7) asulfoneamide series compound selected from (b-7-1) Cyazofamid (b-7-2)Amisulbrom and (b-7-3) Flusulfamide Group (8) a sulfenamide seriescompound selected from (b-8-1) Tolylfluanid and (b-8-2) DichlofluanidGroup (9) a carbamate series compound selected from (b-9-1) Propamocarb(b-9-2) Propamocarb hydrochloride (b-9-3) Diethofencarb and (b-9-4)Pyribencarb Group (10) a dithiocarbamate series compound selected from(b-10-1) Manzeb (Mancozeb) (b-10-2) Maneb (b-10-3) Propineb (b-10-4)Zineb (b-10-5) Metiram (b-10-6) Ziram (b-10-7) Thiuram and (b-10-8)Polycarbamate Group (11) a dicarboxylimide series compound selected from(b-11-1) Iprodione (b-11-2) Procymidone (b-11-3) Captan (b-11-4)Vinclozolin (b-11-5) Chlozolinate and (b-11-6) Folpet Group (12) aguanidine series compound selected from (b-12-1) Iminoctadinetrialbesilate (b-12-2) Iminoctadine-triacetate (b-12-3) Guazatine and(b-12-4) Dodine Group (13) a pyrimidine series compound selected from(b-13-1) Mepanipyrim (b-13-2) Fenarimol (b-13-3) Ferimzone (b-13-4)Cyprodinil (b-13-5) Pyrimethanil (b-13-6) Nuarimol (b-13-7) Dimethirimol(b-13-8) Bupirimate and (b-13-9) Diflumetorim Group (14) a morpholineseries compound selected from (b-14-1) Dimethomorph (b-14-2)Fenpropimorph (b-14-3) Tridemorph (b-14-4) Dodemorph and (b-14-5)Flumorph Group (15) a benzimidazole series compound selected from(b-15-1) Thiophanate (b-15-2) Thiophanatemethyl (b-15-3) Benomyl(b-15-4) Carbendazim (b-15-5) Thiabendazole and (b-15-6) FuberidazoleGroup (16) a pyrrole series compound selected from (b-16-1) Fludioxonil(b-16-2) Fluoroimide and (b-16-3) Fenpiclonil Group (17) anorganophosphorous series compound selected from (b-17-1)Fosetyl-aluminium (b-17-2) Edifenphos (b-17-3) Tolclofos-methyl (b-17-4)Iprobenfos and (b-17-5) Pyrazophos Group (18) a copper series compoundselected from (b-18-1) cupric hydroxide (b-18-2) copper (b-18-3) basiccopper chloride (b-18-4) basic copper sulfate (b-18-5) Oxine-copper(b-18-6) copper sulfate pentahydrate (b-18-7) anhydrous copper sulfate(b-18-8) Copper nonylphenolsulfonate and (b-18-9) dodecylbenzenesulfonicacid bis ethylenediamine copper complex salt Group (19) an antibioticsselected from (b-19-1) Kasugamycin hydrochloride hydrate (b-19-2)Validamycin (b-19-3) Polyoxins A to N (b-19-4) Blastcidin-S benzylaminobenzenesulfonate (b-19-5) Streptomycin (b-19-6) Natamycin (b-19-7)Mildiomycin and (b-19-8) Oxytetracycline Group (20) an organic chlorineseries compound selected from (b-20-1) Chlorothalonil (b-20-2) Phthalideand (b-20-3) Quintozene Group (21) a triazolopyrimidine series compoundselected from (b-21-1)5-Chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo-[1,5-a]pyrimidine(b-21-2)5-Chloro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine(b-21-3)5-Chloro-N-[(1R)-1,2-dimethylpropyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine(b-21-4)5-(Methoxymethyl)-6-octyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine and(b-21-5) 5-Ethyl-6-octyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine Group(22) a benzoyl compound selected from (b-22-1) Metrafenone and (b-22-2)3-(2,3,4-Trimethoxy-6-methylbenzoyl)-5-chloro-2-methoxy-4-methylpyridineGroup (23) an ethylenediamine series compound selected from (b-23-1)Isopropyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)-carbamate(b-23-2)Isopropyl((1S)-2,2-dimethyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)-carbamate(b-23-3)Isopropyl((1S)-1-{[(1-benzofuran-2-ylcarbonyl)amino]methyl}-2-methylpropyl)carbamate(b-23-4)2,2,2-Trifluoroethyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}-propyl)carbamate(b-23-5)2,2,2-Trifluoroethyl((1S)-2,2-dimethyl-1-{[(4-methylbenzoyl)amino]methyl}-propyl)carbamate(b-23-6)2,2,2-Trifluoroethyl((1S)-1-{[(1-benzofuran-2-ylcarbonyl)amino]methyl}-2-methylpropyl)carbamate(b-23-7)2,2,2-Trifluoroethyl{(1S)-1-methyl-2-[(4-methylbenzoyl)amino]ethyl}-carbamate(b-23-8)Benzyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)carbamateand (b-23-9)Isopropyl((1R)-2,2,2-trifluoro-1-{[(4-methylbenzoyl)amino]methyl}ethyl)-carbamateGroup (24) an isoxazolidin series compound selected from (b-24-1)3-[5-(4-Chloro phenyl)-2,3-dimethylisoxazolidin-3-yl]pyridine (b-24-2)3-[2,3-Dimethyl-5-(4-methylphenyl)isoxazolidin-3-yl]pyridine and(b-24-3)3-[2-Isopropyl-3-methyl-5-(4-chlorophenyl)isoxazolidin-3-yl]pyridineGroup (25) a quinoline series compound selected from (b-25-1) Quinoxyfen(b-25-2) [6-(1,1-Dimethylethyl)-8-fluoro-2,3-dimethylquinoline-4-yl]acetate and (b-25-3)[6-(1,1-Dimethylethyl)-8-fluoro-2,3-dimethylquinoline-4-yl]methoxyacetate Group (26) a thiazolidine series compoundselected from (b-26-1)(2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2-ylidene]acetonitrile and (b-26-2)(2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methylphenyl)-1,3-thiazolidin-2-ylidene]acetonitrileGroup (27) a pyrazolinone series compound selected from (b-27-1)1-[(2-Propenylthio)carbonyl]-2-(1-methylethyl)-4-(2-methylphenyl)-5-amino-1H-pyrazol-3-one(b-27-2)1-[(Ethylthio)carbonyl]-2-(1-methylethyl)-4-(2-methylphenyl)-5-amino-1H-pyrazol-3-oneand (b-27-3)1-[(Ethylthio)carbonyl]-2-(1-methylethyl)-4-(2,6-dichlorophenyl)-5-amino-1H-pyrazol-3-oneand Group (28) other fungicide.mildewcide selected from (b-28-1)Hydroxyisoxazol (b-28-2) Fluazinam (b-28-3) Diclomezine (b-28-4)Tricyclazole (b-28-5) Cymoxanil (b-28-6) Famoxadone (b-28-7) Fenamidone(b-28-8) Chloropicrin (b-28-9) Thiadiazine (b-28-10) Proquinazid(b-28-11) Spiroxamine (b-28-12) Fenpropidin (b-28-13) Dithianon(b-28-14) Pencycuron (b-28-15) Isoprothiolane (b-28-16) Probenazole(b-28-17) Resveratrol (b-28-18) Triforine (b-28-19) Acibenzolar-S-methyl(b-28-20) Pyroquilon (b-28-21) Dinocap (b-28-22) Nickelbis(dimethyldithiocarbamate) (b-28-23) Etridiazole (b-28-24) Oxadixyl(b-28-25) Amobam (b-28-26) Pyrifenox (b-28-27) Oxolinic acid (b-28-28)Phosphorous acid (b-28-29) Dazomet (b-28-30) Methyl isothiocyanate(b-28-31) Methasulfocarb (b-28-32) 1,3-dichloropropene (b-28-33) Carbam(b-28-34) Methyl iodide (b-28-35) Sulfur (b-28-36) Lime-sulfur mixedagent (b-28-37) Fentin (b-28-38) Sodium hypochlorite (b-28-39)Chinomethionat (b-28-40) Chloroneb (b-28-41) Anilazine (b-28-42)Nitrothal-isopropyl (b-28-43) Fenitropan (b-28-44) Dicloran and(b-28-45) Benthiazole as effective ingredients.
 2. A controlling methodfor controlling plant diseases comprising applying the plant diseasecontrol composition according to claim
 1. 3. A method for controllingplant diseases, which comprises applying a compound of Group a and acompound of Group b at the same time, or applying either a compound ofGroup a or Group b, and then applying the other compound of Group a orGroup b sequentially, wherein Group a is at least one quinoline compoundselected from the group consisting of: (a-14)3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline,(a-18)3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, and(a-20)3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,or a salt thereof, and Group b is at least one fungicidal compoundselected from the group consisting of Groups (1) to (3) and (5) to (28)below: Group (1) a Strobilurin series compound selected from (b-1-1)Azoxystrobin (b-1-2) Kresoxim-methyl (b-1-3) Pyraclostrobin (b-1-4)Picoxystrobin (b-1-5) Fluoxastrobin (b-1-6) Dimoxystrobin (b-1-7)Orysastrobin (b-1-8) Metominostrobin and (b-1-9) Trifloxystrobin Group(2) a triazole series compound selected from (b-2-1) Simeconazole(b-2-2) Tebuconazole (b-2-3) Fenbuconazole (b-2-4) Hexaconazole (b-2-5)Imibenconazole (b-2-6) Triadimefon (b-2-7) Tetraconazole (b-2-8)Prothioconazole (b-2-9) Triticonazole (b-2-10) Epoxiconazole (b-2-11)Ipconazole (b-2-12) Metconazole (b-2-13) Propiconazole (b-2-14)Cyproconazole (b-2-15) Difenoconazole (b-2-16) Diniconazole (b-2-17)Fluquinconazole (b-2-18) Flusilazole (b-2-19) Penconazole (b-2-20)Bromuconazole (b-2-21) Triadimenol (b-2-22) Flutriafol (b-2-23)Myclobutanil (b-2-24) Etaconazole and (b-2-25) Bitertanol Group (3) animidazole series compound selected from (b-3-1) Oxpoconazole fumarate(b-3-2) Triflumizole (b-3-3) Imazalil (b-3-4) Imazalil-S (b-3-5)Prochloraz (b-3-6) Pefurazoate and (b-3-7) Triazoxide Group (5) anacylalanine series compound selected from (b-5-1) Metalaxyl (b-5-2)Metalaxyl-M (b-5-3) Benalaxyl (b-5-4) Benalaxyl-M and (b-5-5)Furalaxyl-M Group (6) a valineamide series compound selected from(b-6-1) Benthiavalicarb-isopropyl and (b-6-2) Iprovalicarb Group (7) asulfoneamide series compound selected from (b-7-1) Cyazofamid (b-7-2)Amisulbrom and (b-7-3) Flusulfamide Group (8) a sulfenamide seriescompound selected from (b-8-1) Tolylfluanid and (b-8-2) DichlofluanidGroup (9) a carbamate series compound selected from (b-9-1) Propamocarb(b-9-2) Propamocarb hydrochloride (b-9-3) Diethofencarb and (b-9-4)Pyribencarb Group (10) a dithiocarbamate series compound selected from(b-10-1) Manzeb (Mancozeb) (b-10-2) Maneb (b-10-3) Propineb (b-10-4)Zineb (b-10-5) Metiram (b-10-6) Ziram (b-10-7) Thiuram and (b-10-8)Polycarbamate Group (11) a dicarboxylimide series compound selected from(b-11-1) Iprodione (b-11-2) Procymidone (b-11-3) Captan (b-11-4)Vinclozolin (b-11-5) Chlozolinate and (b-11-6) Folpet Group (12) aguanidine series compound selected from (b-12-1) Iminoctadinetrialbesilate (b-12-2) Iminoctadine-triacetate (b-12-3) Guazatine and(b-12-4) Dodine Group (13) a pyrimidine series compound selected from(b-13-1) Mepanipyrim (b-13-2) Fenarimol (b-13-3) Ferimzone (b-13-4)Cyprodinil (b-13-5) Pyrimethanil (b-13-6) Nuarimol (b-13-7) Dimethirimol(b-13-8) Bupirimate and (b-13-9) Diflumetorim Group (14) a morpholineseries compound selected from (b-14-1) Dimethomorph (b-14-2)Fenpropimorph (b-14-3) Tridemorph (b-14-4) Dodemorph and (b-14-5)Flumorph Group (15) a benzimidazole series compound selected from(b-15-1) Thiophanate (b-15-2) Thiophanatemethyl (b-15-3) Benomyl(b-15-4) Carbendazim (b-15-5) Thiabendazole and (b-15-6) FuberidazoleGroup (16) a pyrrole series compound selected from (b-16-1) Fludioxonil(b-16-2) Fluoroimide and (b-16-3) Fenpiclonil Group (17) anorganophosphorous series compound selected from (b-17-1)Fosetyl-aluminium (b-17-2) Edifenphos (b-17-3) Tolclofos-methyl (b-17-4)Iprobenfos and (b-17-5) Pyrazophos Group (18) a copper series compoundselected from (b-18-1) cupric hydroxide (b-18-2) copper (b-18-3) basiccopper chloride (b-18-4) basic copper sulfate (b-18-5) Oxine-copper(b-18-6) copper sulfate pentahydrate (b-18-7) anhydrous copper sulfate(b-18-8) Copper nonylphenolsulfonate and (b-18-9) dodecylbenzenesulfonicacid bis ethylenediamine copper complex salt Group (19) an antibioticsselected from (b-19-1) Kasugamycin hydrochloride hydrate (b-19-2)Validamycin (b-19-3) Polyoxins A to N (b-19-4) Blastcidin-S benzylaminobenzenesulfonate (b-19-5) Streptomycin (b-19-6) Natamycin (b-19-7)Mildiomycin and (b-19-8) Oxytetracycline Group (20) an organic chlorineseries compound selected from (b-20-1) Chlorothalonil (b-20-2) Phthalideand (b-20-3) Quintozene Group (21) a triazolopyrimidine series compoundselected from (b-21-1)5-Chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo-[1,5-a]pyrimidine(b-21-2)5-Chloro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine(b-21-3)5-Chloro-N-[(1R)-1,2-dimethylpropyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine(b-21-4)5-(Methoxymethyl)-6-octyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine and(b-21-5) 5-Ethyl-6-octyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine Group(22) a benzoyl compound selected from (b-22-1) Metrafenone and (b-22-2)3-(2,3,4-Trimethoxy-6-methylbenzoyl)-5-chloro-2-methoxy-4-methylpyridineGroup (23) an ethylenediamine series compound selected from (b-23-1)Isopropyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)-carbamate(b-23-2)Isopropyl((1S)-2,2-dimethyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)-carbamate(b-23-3)Isopropyl((1S)-1-{[(1-benzofuran-2-ylcarbonyl)amino]methyl}-2-methylpropyl)carbamate(b-23-4)2,2,2-Trifluoroethyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}-propyl)carbamate(b-23-5)2,2,2-Trifluoroethyl((1S)-2,2-dimethyl-1-{[(4-methylbenzoyl)amino]methyl}-propyl)carbamate(b-23-6)2,2,2-Trifluoroethyl((1S)-1-{[(1-benzofuran-2-ylcarbonyl)amino]methyl}-2-methylpropyl)carbamate(b-23-7) 2,2,2-Trifluoroethyl{(1S)-1-methyl-2-[(4-methylbenzoyl)amino]ethyl}-carbamate (b-23-8)Benzyl((1S)-2-methyl-1-{[(4-methylbenzoyl)amino]methyl}propyl)carbamateand (b-23-9)Isopropyl((1R)-2,2,2-trifluoro-1-{[(4-methylbenzoyl)amino]methyl}ethyl)-carbamateGroup (24) an isoxazolidin series compound selected from (b-24-1)3-[5-(4-Chloro phenyl)-2,3-dimethylisoxazolidin-3-yl]pyridine (b-24-2)3-[2,3-Dimethyl-5-(4-methylphenyl)isoxazolidin-3-yl]pyridine and(b-24-3)3-[2-Isopropyl-3-methyl-5-(4-chlorophenyl)isoxazolidin-3-yl]pyridineGroup (25) a quinoline series compound selected from (b-25-1) Quinoxyfen(b-25-2) [6-(1,1-Dimethylethyl)-8-fluoro-2,3-dimethylquinoline-4-yl]acetate and (b-25-3)[6-(1,1-Dimethylethyl)-8-fluoro-2,3-dimethylquinoline-4-yl]methoxyacetate Group (26) a thiazolidine series compoundselected from (b-26-1)(2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2-ylidene]acetonitrile and (b-26-2)(2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methylphenyl)-1,3-thiazolidin-2-ylidene]acetonitrileGroup (27) a pyrazolinone series compound selected from (b-27-1)1-[(2-Propenylthio)carbonyl]-2-(1-methylethyl)-4-(2-methylphenyl)-5-amino-1H-pyrazol-3-one(b-27-2)1-[(Ethylthio)carbonyl]-2-(1-methylethyl)-4-(2-methylphenyl)-5-amino-1H-pyrazol-3-oneand (b-27-3)1-[(Ethylthio)carbonyl]-2-(1-methylethyl)-4-(2,6-dichlorophenyl)-5-amino-1H-pyrazol-3-oneand Group (28) other fungicide-mildewcide selected from (b-28-1)Hydroxyisoxazol (b-28-2) Fluazinam (b-28-3) Diclomezine (b-28-4)Tricyclazole (b-28-5) Cymoxanil (b-28-6) Famoxadone (b-28-7) Fenamidone(b-28-8) Chloropicrin (b-28-9) Thiadiazine (b-28-10) Proquinazid(b-28-11) Spiroxamine (b-28-12) Fenpropidin (b-28-13) Dithianon(b-28-14) Pencycuron (b-28-15) Isoprothiolane (b-28-16) Probenazole(b-28-17) Resveratrol (b-28-18) Triforine (b-28-19) Acibenzolar-S-methyl(b-28-20) Pyroquilon (b-28-21) Dinocap (b-28-22) Nickelbis(dimethyldithiocarbamate) (b-28-23) Etridiazole (b-28-24) Oxadixyl(b-28-25) Amobam (b-28-26) Pyrifenox (b-28-27) Oxolinic acid (b-28-28)Phosphorous acid (b-28-29) Dazomet (b-28-30) Methyl isothiocyanate(b-28-31) Methasulfocarb (b-28-32) 1,3-dichloropropene (b-28-33) Carbam(b-28-34) Methyl iodide (b-28-35) Sulfur (b-28-36) Lime-sulfur mixedagent (b-28-37) Fentin (b-28-38) Sodium hypochlorite (b-28-39)Chinomethionat (b-28-40) Chloroneb (b-28-41) Anilazine (b-28-42)Nitrothal-isopropyl (b-28-43) Fenitropan (b-28-44) Dicloran and(b-28-45) Benthiazole.